Amarin Corporation plc
(NASDAQ:AMRN)

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing t...

Website: http://www.amarincorp.com

Founded: 1989

Full Time Employees: 965

Sector: Healthcare

Industry: Biotechnology

Pharmaceuticals Cardiovascular

Share this website to your friends

• Market Cap:

• Exchange:

• Shs Outstanding:

• Employees:

• Beta:

• Return on Equity (ROE) ttm:

• Return on Assets (ROA) ttm:

• EPS ttm:

• Book value per Share:

• Cash per Share:

• Current ast per Share:

• P/E ttm:

• P/E forward:

• P/E ttm high:

• P/E ttm low:

• P/S ttm:

• P/B ttm:

• P/FCF ttm:

• PEG ratio:

• Cash Ratio ttm:

• Quick Ratio ttm:

• Current Ratio ttm:

• Gross Mgn ttm:

• EBITDA Mgn ttm:

• Operating Mgn ttm:

• Net Income Mgn ttm:

• Trailing Div yield:

• Forward Div yield:

• Payout Ratio ttm:

• Ex-Dividend date:

• Target Price High:

• Target Price Low:

• Target Price Mean:

• Number of Analysts:

• Debt Ratio ttm:

• Debt to Equity ttm:

• Total Net Debt:

At a glance:

Bull Thesis:

Bear Thesis:

Main Competitors:

Moat:

Income Statements:

Quarterly

Annual

Unit: USD	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-11-10	2009-12-31	2009-07-01	2008-09-25	2008-05-19	2007-11-20	2007-08-01	2007-05-10	2007-02-08	2007-01-25	2006-11-09	2006-09-06	2006-08-03	2006-05-11	2006-02-09	2005-09-30	2004-12-31	2004-09-30	2003-12-31	2002-12-31	2001-12-31

product revenue	46,543,000	48,558,000	46,617,000	41,035,000	60,068,000	41,852,000	47,514,000	55,156,000	70,555,000	64,903,000	65,187,000	84,654,000	89,507,000	89,222,000	93,796,000	93,986,000	143,722,000	141,442,000	153,773,000	141,383,000	165,907,000	155,190,000	133,724,000	152,204,000	142,044,000	112,250,000	100,366,000	72,731,000	77,085,000	54,973,000	52,537,000	43,777,000	53,482,000	47,051,000	44,948,000	34,344,000	38,403,000	32,441,000	32,815,000	25,307,000	26,402,000	21,320,000	17,707,000	15,558,000
licensing and royalty revenue	2,676,000	1,112,000	26,124,000	982,000	2,238,000	446,000	19,977,000	1,363,000	4,158,000	1,153,000	14,980,000	1,321,000	738,000	656,000	644,000	644,000	769,000	596,000	715,000	787,000	1,344,000	1,309,000	1,593,000	2,789,000
total revenue	49,219,000	49,670,000	72,741,000	42,017,000	62,306,000	42,298,000	67,491,000	56,519,000	74,713,000	66,056,000	80,167,000	85,975,000	90,245,000	89,878,000	94,440,000	94,630,000	144,491,000	142,038,000	154,488,000	142,170,000	167,251,000	156,499,000	135,317,000	154,993,000	143,277,000	112,408,000	100,792,000	73,278,000	77,330,000	55,323,000	52,643,000	43,919,000	53,866,000	47,360,000	45,241,000	34,637,000	38,696,000	32,734,000	33,111,000	25,543,000	26,633,000	21,483,000	17,707,000	15,933,000
yoy	-21.00%	17.43%	7.78%	-25.66%	-16.61%	-35.97%	-15.81%	-34.26%	-17.21%	-26.50%	-15.11%	-9.15%	-37.54%	-36.72%	-38.87%	-33.44%	-13.61%	-9.24%	14.17%	-8.27%	16.73%	39.22%	34.25%	111.51%	85.28%	103.18%	91.46%	66.85%	43.56%	16.81%	16.36%	26.80%	39.20%	44.68%	36.63%	35.60%	45.29%	52.37%	86.99%	60.32%
qoq	-0.91%	-31.72%	73.12%	-32.56%	47.30%	-37.33%	19.41%	-24.35%	13.11%	-17.60%	-6.76%	-4.73%	0.41%	-4.83%	-0.20%	-34.51%	1.73%	-8.06%	8.66%	-15.00%	6.87%	15.65%	-12.69%	8.18%	27.46%	11.52%	37.55%	-5.24%	39.78%	5.09%	19.86%	-18.47%	13.74%	4.68%	30.61%	-10.49%	18.21%	-1.14%	29.63%	-4.09%	23.97%	21.32%	11.13%
less: cost of goods sold	26,050,000	27,462,000	22,379,000	16,887,000	35,399,000	26,022,000	24,722,000	24,615,000	29,589,000	23,560,000	23,199,000	25,794,000	26,641,000	23,941,000	35,810,000	22,239,000	30,635,000	30,211,000	32,155,000	28,326,000	34,768,000	33,071,000	28,797,000	34,807,000	30,665,000	25,444,000	22,770,000	17,140,000	17,508,000	13,541,000	12,846,000	10,648,000	13,432,000	11,921,000	11,401,000	8,198,000	10,155,000	8,451,000	8,861,000	6,896,000	8,389,000	7,478,000	6,381,000	5,627,000	5,848,000	5,366,000	5,025,000	4,246,000
gross margin	23,169,000	22,208,000	50,362,000	25,130,000	-9,567,000	16,276,000	42,769,000	31,904,000	45,124,000	29,822,000	42,668,000	47,927,000	63,604,000	62,859,000	43,630,000	72,391,000	113,856,000	111,827,000	122,333,000	113,844,000	132,483,000	123,428,000	106,520,000	120,186,000	112,612,000	86,964,000	78,022,000	56,138,000	59,822,000	41,782,000	39,797,000	33,271,000	40,434,000	35,439,000	33,840,000	26,439,000	28,541,000	24,283,000	24,250,000	18,647,000	18,244,000	14,005,000	11,326,000	10,306,000	10,632,000	8,783,000	7,581,000	6,721,000
yoy	-342.18%	36.45%	17.75%	-21.23%	-121.20%	-45.42%	0.24%	-33.43%	-29.05%	-52.56%	-2.20%	-33.79%	-44.14%	-43.79%	-64.34%	-36.41%	-14.06%	-9.40%	14.85%	-5.28%	17.65%	41.93%	36.53%	114.09%	88.25%	108.14%	96.05%	68.73%	47.95%	17.90%	17.60%	25.84%	41.67%	45.94%	39.55%	41.79%	56.44%	73.39%	114.11%	80.93%	71.60%	59.46%	49.40%	53.34%
qoq	4.33%	-55.90%	100.41%	-362.67%	-158.78%	-61.94%	34.06%	-29.30%	51.31%	-30.11%	-10.97%	-24.65%	1.19%	44.07%	-39.73%	-36.42%	1.81%	-8.59%	7.46%	-14.07%	7.34%	15.87%	-11.37%	6.73%	29.49%	11.46%	38.98%	-6.16%	43.18%	4.99%	19.61%	-17.72%	14.09%	4.73%	27.99%	-7.36%	17.53%	0.14%	30.05%	2.21%	30.27%	23.65%	9.90%	-3.07%	21.05%	15.86%	12.80%
gross margin %	47.07%	44.71%	69.23%	59.81%	-15.35%	38.48%	63.37%	56.45%	60.40%	45.15%	53.22%	55.75%	70.48%	69.94%	46.20%	76.50%	78.80%	78.73%	79.19%	80.08%	79.21%	78.87%	78.72%	77.54%	78.60%	77.36%	77.41%	76.61%	77.36%	75.52%	75.60%	75.76%	75.06%	74.83%	74.80%	76.33%	73.76%	74.18%	73.24%	73.00%	68.50%	65.19%	63.96%	64.68%	Infinity%	Infinity%	Infinity%	Infinity%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%
operating expenses:
selling, general and administrative	20,059,000	19,697,000	38,673,000	36,573,000	36,970,000	36,904,000	38,547,000	39,889,000	43,941,000	45,457,000	50,953,000	59,587,000	68,131,000	58,745,000	86,893,000	90,647,000	92,368,000	102,965,000	107,203,000	105,798,000	116,816,000	120,164,000	92,395,000	133,937,000	96,025,000	82,559,000	73,406,000	71,633,000	79,686,000	49,960,000	53,944,000	43,407,000	35,639,000	33,194,000	31,545,000	34,171,000	31,225,000	26,061,000	26,066,000	28,020,000	23,519,000	26,727,000	26,054,000	24,741,000	18,397,000	19,270,000	21,094,000	20,585,000	22,293,000	28,274,000	33,961,000	39,267,000
research and development	5,371,000	4,208,000	4,915,000	5,312,000	5,985,000	4,540,000	4,746,000	5,598,000	5,791,000	5,105,000	5,642,000	5,681,000	5,239,000	5,765,000	9,356,000	10,051,000	5,753,000	7,820,000	6,357,000	9,377,000	8,509,000	10,204,000	9,969,000	10,278,000	11,097,000	8,923,000	7,130,000	7,242,000	11,907,000	14,072,000	18,159,000	11,762,000	11,947,000	10,694,000	13,694,000	10,823,000	10,177,000	13,490,000	12,578,000	13,730,000	13,347,000	13,092,000	12,009,000	12,614,000	12,435,000	14,457,000	11,727,000	11,707,000	16,602,000	16,821,000	17,489,000	21,838,000	19,221,000	20,913,000	14,066,000	4,756,000	5,951,000	6,013,000	5,189,000	4,449,000		15,282,000		10,963	1,971	1,748	2,237	2,409	4,378	5,051		4,711		3,800	2,898	2,419
restructuring	4,064,000	9,406,000	22,759,000						229,000	711,000	10,032,000		-180,000	3,493,000	10,213,000		-398,000	14,115,000
total operating expenses	29,494,000	33,311,000	66,347,000	41,885,000	42,955,000	41,444,000	43,293,000	45,487,000	49,961,000	51,273,000	66,627,000	65,268,000	73,190,000	68,003,000	106,462,000	100,698,000	97,723,000	124,900,000	113,560,000	115,175,000	125,325,000	130,368,000	102,364,000	144,215,000	107,122,000	91,482,000	80,536,000	78,875,000	91,593,000	64,032,000	72,103,000	55,169,000	47,586,000	43,888,000	45,239,000	44,994,000	41,402,000	39,551,000	38,644,000	41,750,000	36,866,000	39,819,000	38,063,000	37,355,000	30,832,000	33,727,000	32,821,000	32,292,000	42,994,000	48,777,000	54,294,000	62,392,000	35,956,000	34,310,000	27,701,000	18,783,000	12,325,000	9,446,000	15,214,000	7,175,000				28,180	6,749	7,733	6,890	16,437	9,673	8,582		8,357		7,945	6,777	5,824
operating income	-6,325,000	-11,103,000	-15,985,000	-16,755,000	-52,522,000	-25,168,000	-524,000	-13,583,000	-4,837,000	-21,451,000	-23,959,000	-17,341,000	-9,586,000	-5,144,000	-62,832,000	-28,307,000	16,133,000	-13,073,000	8,773,000	-1,331,000	7,158,000	-6,940,000	4,156,000	-24,029,000	5,490,000	-4,518,000	-2,514,000	-22,737,000	-31,771,000	-22,250,000	-32,306,000	-21,898,000	-7,152,000	-8,449,000	-11,399,000	-18,555,000	-12,861,000	-15,268,000	-14,394,000	-23,103,000	-18,622,000	-25,814,000	-26,737,000	-27,049,000	-20,200,000	-24,944,000	-25,240,000	-25,571,000	-32,888,000	-40,374,000	-48,794,000	-60,051,000	-35,956,000	-34,310,000	27,701,000	-18,783,000	-12,325,000	-9,446,000	15,214,000	-7,175,000		19,575,000											-14,722
yoy	-87.96%	-55.88%	2950.57%	23.35%	985.84%	17.33%	-97.81%	-21.67%	-49.54%	317.01%	-61.87%	-38.74%	-159.42%	-60.65%	-816.20%	2026.75%	125.38%	88.37%	111.09%	-94.46%	30.38%	53.61%	-265.31%	5.68%	-117.28%	-79.69%	-92.22%	3.83%	344.23%	163.34%	183.41%	18.02%	-44.39%	-44.66%	-20.81%	-19.69%	-30.94%	-40.85%	-46.16%	-14.59%	-7.81%	3.49%	5.93%	5.78%	-38.58%	-38.22%	-48.27%	-57.42%	-8.53%	17.67%	-276.15%	219.71%	191.73%	263.22%	82.08%	161.78%		-148.26%
qoq	-43.03%	-30.54%	-4.60%	-68.10%	108.69%	4703.05%	-96.14%	180.81%	-77.45%	-10.47%	38.16%	80.90%	86.35%	-91.81%	121.97%	-275.46%	-223.41%	-249.01%	-759.13%	-118.59%	-203.14%	-266.99%	-117.30%	-537.69%	-221.51%	79.71%	-88.94%	-28.43%	42.79%	-31.13%	47.53%	206.18%	-15.35%	-25.88%	-38.57%	44.27%	-15.76%	6.07%	-37.70%	24.06%	-27.86%	-3.45%	-1.15%	33.91%	-19.02%	-1.17%	-1.29%	-22.25%	-18.54%	-17.26%	-18.75%	67.01%	4.80%	-223.86%	-247.48%	52.40%	30.48%	-162.09%	-312.04%
operating margin %	-12.85%	-22.35%	-21.98%	-39.88%	-84.30%	-59.50%	-0.78%	-24.03%	-6.47%	-32.47%	-29.89%	-20.17%	-10.62%	-5.72%	-66.53%	-29.91%	11.17%	-9.20%	5.68%	-0.94%	4.28%	-4.43%	3.07%	-15.50%	3.83%	-4.02%	-2.49%	-31.03%	-41.08%	-40.22%	-61.37%	-49.86%	-13.28%	-17.84%	-25.20%	-53.57%	-33.24%	-46.64%	-43.47%	-90.45%	-69.92%	-120.16%	-151.00%	-169.77%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	Infinity%	-Infinity%	-Infinity%	-Infinity%	Infinity%	-Infinity%	NaN%	Infinity%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	-Infinity%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%
interest income	2,576,000	2,783,000	2,620,000	2,872,000	3,375,000	3,374,000	3,271,000	3,383,000	3,425,000	3,216,000	3,001,000	2,221,000	1,578,000	750,000	288,000	203,000	301,000	163,000	285,000	471,000	2,993,000	549,000	151,000	1,208,000	8,261,000	1,146,000	789,000																										13,382,000	-4,570,000		-3,951,000	134,000	3,000		1,000
other income	2,904,000	205,000	-85,000	253,000	-753,000	265,000	145,000	1,545,000	-1,029,000	-575,000	3,043,000	624,000	1,250,000	511,000	-2,255,000	-246,000	88,000	-57,000	-191,000		54,000	33,000	108,000	-91,000				3,000	-192,000	-58,000	-131,000	55,000	-26,000	25,000	80,000	-5,000			-182,000	-121,000	-93,000	-102,000	95,000	-128,000	-267,000	-247,000	4,225,000	16,000	-351,000	-302,000	-411,000	-124,000	-16,000	-427,000		68,000	-40,000	-59,000		77,000
loss from operations before taxes	-852,000	-8,115,000		-13,630,000	-49,907,000	-21,529,000		-8,655,000	-12,805,250	-18,810,000	-17,915,000	-14,496,000	-24,258,000	-3,883,000						-1,002,000	7,600,000	-6,358,000		-22,912,000	7,232,000	-3,462,000	-1,820,000	-24,431,000	-33,573,000	-24,471,000	-34,210,000	-24,095,000					-15,307,250	-16,787,000	-14,382,000		-23,713,500	-31,207,000			-8,855,500	-25,601,000		-25,555,000				-65,415,000			51,000,000				200,468,000
benefit from income taxes	-594,500	377,000					-1,370,000																														583,000	1,015,000	1,028,000	289,000	1,545,000	532,000			-321,250	-449,000	-411,000	-425,000	-1,633,000	1,635,000	-65,000	3,257,000
net income	-1,224,000	-7,738,000	-14,139,000	-15,697,000	-48,618,000	-25,134,000	1,522,000	-9,953,000	-5,781,000	-19,311,000	-17,560,000	-16,460,000	856,000	-5,140,000	-69,956,000	-31,563,000	14,698,000	-13,151,000	7,808,000	-1,626,000	4,926,000	-6,788,000	4,415,000	-20,553,000	7,068,000	-3,462,000	-1,820,000	-24,431,000	-33,669,000	-24,471,000	-34,210,000	-24,095,000	-22,465,000	-10,825,000	-13,634,000	-20,941,000	-27,453,000	-15,772,000	-13,354,000	-29,771,000	-21,891,000	-30,675,000	-31,512,000	-31,126,000	-19,657,000	-26,050,000	15,323,000	-25,980,000	-15,411,000	-48,884,000	-39,774,000	-62,158,000	-10,567,000	-26,426,000	53,904,000	-88,285,000
yoy	-97.48%	-69.21%	-1028.98%	57.71%	741.00%	30.15%	-108.67%	-39.53%	-775.35%	275.70%	-74.90%	-47.85%	-94.18%	-60.92%	-995.95%	1841.14%	198.38%	93.74%	76.85%	-92.09%	-30.31%	96.07%	-342.58%	-15.87%	-120.99%	-85.85%	-94.68%	1.39%	49.87%	126.06%	150.92%	15.06%	-18.17%	-31.37%	2.10%	-29.66%	25.41%	-48.58%	-57.62%	-4.35%	11.36%	17.75%	-305.65%	19.81%	27.55%	-46.71%	-138.53%	-58.20%	45.84%	84.98%	-173.79%	-29.59%
qoq	-84.18%	-45.27%	-9.93%	-67.71%	93.44%	-1751.38%	-115.29%	72.17%	-70.06%	9.97%	6.68%	-2022.90%	-116.65%	-92.65%	121.64%	-314.74%	-211.76%	-268.43%	-580.20%	-133.01%	-172.57%	-253.75%	-121.48%	-390.79%	-304.16%	90.22%	-92.55%	-27.44%	37.59%	-28.47%	41.98%	7.26%	107.53%	-20.60%	-34.89%	-23.72%	74.06%	18.11%	-55.14%	36.00%	-28.64%	-2.66%	1.24%	58.35%	-24.54%	-270.01%	-158.98%	68.58%	-68.47%	22.90%	-36.01%	488.23%	-60.01%	-149.02%	-161.06%
net income margin %	-2.49%	-15.58%	-19.44%	-37.36%	-78.03%	-59.42%	2.26%	-17.61%	-7.74%	-29.23%	-21.90%	-19.15%	0.95%	-5.72%	-74.07%	-33.35%	10.17%	-9.26%	5.05%	-1.14%	2.95%	-4.34%	3.26%	-13.26%	4.93%	-3.08%	-1.81%	-33.34%	-43.54%	-44.23%	-64.98%	-54.86%	-41.71%	-22.86%	-30.14%	-60.46%	-70.95%	-48.18%	-40.33%	-116.55%	-82.20%	-142.79%	-177.96%	-195.36%	-Infinity%	-Infinity%	Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	Infinity%	-Infinity%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%
loss per ordinary share:
basic	-22.5	-20
diluted	-22.5	-20
weighted-average ordinary shares:
basic	414,984	415,531,000	414,477,000	413,422	410,937	411,150	410,851	410,146	407,655	408,417	407,848	406,177	401,155	404,614	398,187	397,805	395,992	396,618	395,899	394,638	381,759	389,699	384,663	361,136	342,538	350,994	330,863	328,712	297,237	295,595	293,662	285,207	270,652	270,803	270,725	270,163	211,874	209,149	184,471	184,052	180,654	183,245	180,464	175,582	173,719	174,502	172,886	172,872	161,022					149,200		136,011		133,238		123,426
diluted	414,984	415,531,000	414,477,000	413,422	410,937	411,150	411,395	410,146	407,655	408,417	407,848	406,177	401,155	404,614	398,187	397,805	402,480	396,618	401,767	394,638	381,759	389,699	399,664	361,136	342,538	350,994	330,863	328,712	297,237	295,595	293,662	285,207	270,652	270,803	270,725	270,163	211,874	209,149	184,471	184,052	180,654	183,245	180,464	175,582	173,824	175,141	207,674	174,431	167,070					149,200		136,011		155,975		151,500
income from operations before taxes			-13,450,000				2,892,000								-64,799,000	-28,350,000	16,393,000	-12,967,000	8,867,000				4,415,000										-11,350,000	-10,825,000	-13,634,000	-20,941,000				-30,060,000			-32,049,000	-31,598,000			15,734,000						-40,682,250	-22,853,000		-88,875,000	-21,278,000	97,112,000		18,245,000
provision for income taxes			-689,000	-2,067,000	1,289,000	-3,605,000		-1,298,000	-3,332,000	-501,000																																											-1,472,000	-3,573,000	2,904,000		-588,000	-767,000	1,635,000
earnings per ordinary share:
basic			-30
diluted			-30
loss per share:
basic				-0.04	-0.12	-0.06		-0.02	-0.033	-0.05	-0.04	-0.04	-0.068	-0.01		-0.08	-0.005	-0.03			0.01	-0.02		-0.06	0.02	-0.01	-0.01	-0.07	-0.11	-0.08	-0.12	-0.08	-0.08	-0.04	-0.05	-0.08	-0.1	-0.08	-0.07	-0.16	-0.12	-0.18		-0.18	-0.11	-0.15		-0.15																-0.96		-0.72				-0.07		-0.09			-0.08
diluted				-0.04	-0.12	-0.06		-0.02	-0.033	-0.05	-0.04	-0.04	-0.068	-0.01		-0.08	-0.005	-0.03			0.01	-0.02		-0.06	0.02	-0.01	-0.01	-0.07	-0.11	-0.08	-0.12	-0.08	-0.08	-0.04	-0.05	-0.08	-0.1	-0.08	-0.07	-0.16	-0.12	-0.18		-0.18	-0.11	-0.17		-0.15																-0.96		-0.72									-0.08
weighted-average shares:
basic	414,984	415,531,000	414,477,000	413,422	410,937	411,150	410,851	410,146	407,655	408,417	407,848	406,177	401,155	404,614	398,187	397,805	395,992	396,618	395,899	394,638	381,759	389,699	384,663	361,136	342,538	350,994	330,863	328,712	297,237	295,595	293,662	285,207	270,652	270,803	270,725	270,163	211,874	209,149	184,471	184,052	180,654	183,245	180,464	175,582	173,719	174,502	172,886	172,872	161,022					149,200		136,011		133,238		123,426
diluted	414,984	415,531,000	414,477,000	413,422	410,937	411,150	411,395	410,146	407,655	408,417	407,848	406,177	401,155	404,614	398,187	397,805	402,480	396,618	401,767	394,638	381,759	389,699	399,664	361,136	342,538	350,994	330,863	328,712	297,237	295,595	293,662	285,207	270,652	270,803	270,725	270,163	211,874	209,149	184,471	184,052	180,654	183,245	180,464	175,582	173,824	175,141	207,674	174,431	167,070					149,200		136,011		155,975		151,500
less: cost of goods sold - restructuring inventory										12,674,000	14,300,000	12,254,000		3,078,000	15,000,000
earnings per share:
basic															-0.18				0.02				0.01																				-0.35				0.09
diluted															-0.18				0.02				0.01																				-0.35				0.08
income tax benefit											355,000						-466,750	-184,000	-1,059,000	-624,000	482,250	-430,000		2,359,000
income tax provision												-1,964,000	-2,406,750	-1,257,000	-5,157,000	-3,213,000
other expense																				-142,000					-45,500	-90,000	-95,000										-95,250	-78,000																	52,000				-11,000
licensing revenue																									1,233,000	158,000	426,000	547,000	245,000	350,000	106,000	142,000	384,000	309,000	293,000	293,000	293,000	293,000	296,000	236,000	231,000	163,000		375,000
interest expense																												-1,697,000	-2,684,000	-2,163,000	-1,773,000	-2,252,000	-2,669,000	-2,401,000	-2,315,000	-2,381,000	-2,424,000	-5,051,000	-5,616,000	-5,586,000	-5,427,000	-5,061,000	-4,807,000	-4,885,000	-5,010,000	-4,876,000	-4,296,000	-4,393,000	-7,533,000	-8,441,000	-9,345,000	-8,860,000			4,317,000				-94,000
gain on change in fair value of derivative liabilities																																						3,610,000	5,810,000	-1,250,000	-740,000	-230,000	-600,000	464,000	1,602,000	4,466,000	3,011,000	4,393,000	26,651,000	-1,402,000	18,841,000	3,620,000
loss on change in fair value of derivative liabilities
preferred stock purchase option																																												-868,000
preferred stock beneficial conversion features																																										-1,646,000
net loss applicable to common shareholders																																					-14,724,250	-15,772,000	-13,354,000		-31,792,000	-32,321,000
preferred stock beneficial conversion feature																																											-31,341,000
net income applicable to common shareholders																																								-29,771,000			-62,853,000	-31,994,000
gain on extinguishment of debt																																															38,034,000
benefit from (benefit from) income taxes																																											537,000	472,000
product revenues																																													16,480,000	14,149,000	12,606,000	10,967,000	4,061,250	8,403,000	5,500,000	2,341,000
cost of goods sold																																																	4,099,000	3,682,000	2,844,000	1,287,000
loss from operations before income taxes																																																	-38,910,750	-50,519,000	-39,709,000
loss per share:
basic and diluted																																																	-0.24	-0.29	-0.26	-0.41			0.38				1.58
weighted-average shares:
basic and diluted																																																		170,187	150,694	150,430	144,017,000		140,550		130,247,000		128,360		100,239,000
revenues
marketing, general and administrative																																																					16,735,000	13,397,000	13,635,000	14,027,000	4,046,250	3,433,000	10,025,000	2,726,000
gain on change in fair value of derivative liability																																																					-17,171,500	16,454,000		-66,209,000	30,734,000	106,614,000		25,342,000
income per share:
basic																																																					-0.298	-0.18		-0.65	-0.17	0.72		0.15
diluted																																																					-0.298	-0.18		-0.65	-0.17	0.62		0.12
loss on change in fair value of derivative liability																																																							18,930,000				185,359,000
benefit for income taxes																																																								590,000				49,000
net and comprehensive income																																																									-21,866,000	96,345,000		18,294,000
net and comprehensive loss																																																											202,103,000
revenue																																																																						400		100
operating expenses																																																																28,180	6,749	7,733	6,890	16,437	9,673	8,582		8,357	14,722	7,945	6,777
general and administrative																																																														4,293,000
finance income																																																														-499,000		9,627	6,915	-139	821	648	552
finance costs																																																														21,000
loss before tax																																																														19,097,000
income tax/																																																														34,000
loss for the period attributable to equity holders of the parent																																																														19,131,000
basic loss per ordinary share																																																														-190
diluted loss per ordinary share																																																														-190
shares used in calculation of basic and diluted loss per share																																																														98,828,575
revenue:
total revenues																																																																												500
selling, general & administrative																																																																11,423	3,842	3,222	3,112	3,779	3,996	2,891		2,912	5,990	3,160	2,830	2,584	4,752		2,962
amortisation of intangible assets																																																																					169	170		169		168	169	169			288
share-based compensation																																																																4,633	936	865	1,541	1,465	1,130	470		565	1,166	817	349
reorganization costs																																																																1,161		1,898
impairment of intangible assets
total research & development																																																																12,954	2,218	2,120	2,615	2,756	4,617	5,206		4,897		4,070	2,898	2,419
total selling, general & administrative																																																																15,226	4,531	5,613	4,275	13,681	5,056	3,376		3,460		3,875	3,530	3,405
total operating income																																																																-28,180
finance expense																																																																-3,330	-109	-183
loss before taxes																																																																-21,883
income tax credit																																																																674	194	172	179	169	317	128		118		163	390
net loss for the period																																																																-21,209
weighted average shares - basic																																																																22,064
gross profit																																																																						400		100
impairment of intangible fixed assets																																																																				8,784
categorized as follows:
total operating																																																																	-6,749	-7,733	-6,890	-16,437	-9,673							-5,324
profit/(loss) before taxes																																																																	57
net profit/(loss) for the period																																																																	251
weighted-average shares – basic																																																																	20,118
income/(loss) per share:
basic																																																																	0.01
weighted-average shares - diluted																																																																	20,118
diluted																																																																	0.01
amortization of intangible assets																																																																									337				337
(loss) before taxes																																																																		-8,055	-6,069	-15,789	-9,121
net (loss) for the period																																																																		-7,883	-5,890	-15,620	-8,804
weighted-average shares – basic*																																																																		11,013
weighted-average shares: - basic																																																																			97,566
(loss)/income per share: -
basic																																																																			-0.06	-0.17	-0.1							-0.1
diluted																																																																			-0.06	-0.17	-0.1							-0.1
weighted-average shares - basic																																																																				92,948	90,484	88,326		81,412		81,202	78,307	54,085
(loss)/income per share:
basic																																																																			-0.06	-0.17	-0.1							-0.1
diluted																																																																			-0.06	-0.17	-0.1							-0.1
group restructuring																																																																									531		531
operating income on ordinary activities before interest																																																																						-8,182		-8,257		-7,945	-6,777
net interest receivable/																																																																						1,555		884		970	33
income before taxes																																																																						-6,627		-7,373		-6,975	-6,744
net income for the period																																																																						-6,499		-7,255		-6,812	-6,354
loss per share:
basic				-0.04	-0.12	-0.06		-0.02	-0.033	-0.05	-0.04	-0.04	-0.068	-0.01		-0.08	-0.005	-0.03			0.01	-0.02		-0.06	0.02	-0.01	-0.01	-0.07	-0.11	-0.08	-0.12	-0.08	-0.08	-0.04	-0.05	-0.08	-0.1	-0.08	-0.07	-0.16	-0.12	-0.18		-0.18	-0.11	-0.15		-0.15																-0.96		-0.72				-0.07		-0.09			-0.08
* see note 4
research & development																																																																									6,698				3,862
unaudited
turnover
cost of sales
interest receivable and similar income
interest payable and similar charges
loss on ordinary activities before tax
tax on loss on ordinary activities																																																																									4
retained loss for the financial period
diluted loss per share
loss per share:
basic -																																																																										-0.08
* see note 5 over page
revenues from continuing activities																																																																												500
revenues from discontinued activities																																																																															1,017
cost of sales:
direct costs
cost of sales from discontinued activities																																																																															107
continuing activities																																																																												500
discontinued activities
total gross profit																																																																												500
company restructuring																																																																												652
non recurring payment
operating expenses from continuing activities																																																																												5,824	8,951		3,250
research & development from discontinued activities																																																																															1,383
selling, general & administrative from discontinued activities
other income - valeant settlement
operating expenses from discontinued activities
operating (loss) from continuing activities																																																																												-5,324	-8,951
operating (loss) on discontinued activities
exceptional income/(expense) - discontinued activities
escrow proceeds of q4 2003 swedish disposal
(loss) on disposal of us operations and certain products
gain on settlement of debt on related sale of distribution rights																																																																													5		6
(loss)/profit on ordinary activities before interest
net interest (payable)/receivable and similar (charges)/credits																																																																												-39
(loss)/income before taxes																																																																												-5,363
income tax credit/																																																																												163
dividend credit
net (loss)/income for the period																																																																												-5,200
revenue from continuing activities
gross profit:
gross profit from discontinued activities																																																																															910
total gross profit:																																																																															910
total operating expenses from discontinued activities																																																																															2,958
total operating (loss) on discontinued activities
exceptional income — discontinued activities
escrow proceeds from disposal of swedish business
loss on disposal of us operations and certain products																																																																															5
gain on settlement of elan debt
profit on ordinary activities before interest from discontinued activities
discontinued operations
continuing operations
profit on disposal of swedish operations																																																																													3		4
profit on ordinary activities before tax
tax on profit on ordinary activities																																																																													6		8
retained profit for the financial period
basic profit per ordinary share
diluted profit per share
selling, general & administrative pre-exceptional item																																																																															1,575
adjustment to deferred consideration relating to distribution rights
total selling, general & administrative from discontinued activities																																																																															1,575
exceptional income - discontinued activities
escrow proceeds from disposal of swedish business in q4 2003																																																																															350
(loss) on ordinary activities before interest from discontinued activities
operating income/
operating profit
profit for the financial period
dividends — non-equity
earnings per ordinary share
diluted earnings per share

Balance Sheets:

Quarterly

Annual

Unit: USD	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-11-10	2009-12-31	2009-12-09	2009-11-23	2009-07-01	2009-06-30	2008-12-31	2008-09-25	2008-06-30	2008-05-19	2007-12-31	2007-11-27	2007-11-20	2007-08-01	2007-06-30	2007-05-19	2007-05-10	2007-05-04	2006-12-31	2006-09-06	2005-12-31	2005-09-30	2004-12-31	2004-09-30	2004-02-09	2004-01-31	2003-09-30	2002-12-31	2001-12-31	2000-12-31

assets
current assets:
cash and cash equivalents	134,660,000	122,802,000	147,877,000	119,524,000	121,038,000	156,944,000	215,924,000	213,944,000	199,252,000	270,814,000	232,995,000	191,412,000	217,666,000	240,498,000	228,001,000	219,151,000	219,454,000	222,875,000	327,016,000	290,994,000	186,964,000	207,207,000	214,007,000	329,045,000	644,588,000	673,207,000	221,771,000	211,089,000	249,227,000	81,892,000	102,257,000	129,049,000	73,637,000	79,086,000	85,464,000	96,076,000	98,251,000	117,562,000	72,491,000	81,363,000	106,961,000	118,976,000	136,050,000	161,195,000	119,539,000	135,435,000	150,528,000	164,278,000	191,514,000	225,885,000	149,426,000	201,780,000	260,242,000	215,110,000	250,255,000	245,822,000	116,602,000	125,855,000	131,446,000	129,482,000	31,442,000	37,745,000		1,635	11,239		1,635	11,239		26,340		18,303	198		27,610	27,610			36,802
restricted cash	201,000	301,000	300,000	300,000	300,000	526,000	525,000	525,000	525,000	524,000	524,000	523,000	523,000	3,920,000	3,918,000	3,918,000	3,918,000	3,917,000	3,917,000	3,917,000	3,915,000	3,915,000	3,913,000	3,910,000	3,907,000	3,904,000	1,503,000	1,502,000	1,500,000	600,000	600,000	600,000	600,000	600,000	600,000	600,000	600,000	600,000	600,000	600,000	600,000	600,000	600,000	600,000	600,000	600,000	600,000	600,000	1,000,000	1,400,000	1,400,000	1,400,000
short-term investments	167,929,000	163,785,000	150,827,000	162,263,000	173,182,000	148,788,000	90,739,000	94,235,000	121,407,000	49,848,000	79,919,000	112,959,000	91,695,000	63,203,000	85,232,000	143,406,000	234,674,000	256,267,000	181,910,000	223,742,000	313,969,000	354,655,000	336,273,000	213,190,000
accounts receivable	126,832,000	127,309,000	119,130,000	106,734,000	122,279,000	112,642,000	123,691,000	115,806,000	133,563,000	122,400,000	122,730,000	133,236,000	130,990,000	123,379,000	143,942,000	110,234,000	163,653,000	149,361,000	182,259,000	151,275,000	154,574,000	147,292,000	124,985,000	158,288,000	116,430,000	103,583,000	95,398,000	79,485,000	66,523,000	47,648,000	50,309,000	39,180,000	45,318,000	34,610,000	37,475,000	29,450,000	19,985,000	17,504,000	17,639,000	15,019,000	13,826,000	11,239,000	9,943,000	8,545,000	7,842,000	6,667,000	6,364,000	4,025,000	3,645,000	3,721,000	2,267,000	3,441,000																																						4,960	2,856
inventory	195,910,000	184,703,000	171,244,000	159,490,000	166,048,000	224,000,000	239,408,000	255,280,000	258,616,000	254,461,000	227,021,000	225,813,000	228,732,000	227,606,000	225,772,000	267,818,000	234,676,000	309,268,000	272,455,000	230,892,000	188,864,000	148,531,000	124,844,000	92,121,000	76,769,000	54,557,000	46,268,000	57,909,000	57,802,000	43,673,000	40,093,000	35,104,000	30,260,000	28,550,000	24,814,000	23,879,000	20,507,000	19,773,000	20,306,000	21,344,000	18,985,000	19,704,000	20,499,000	16,183,000						27,083,000	28,514,000	27,435,000	21,262,000	8,989,000
prepaid and other current assets	24,350,000	29,434,000	17,441,000	24,750,000	12,552,000	7,316,000	31,552,000	8,142,000	11,618,000	19,464,000	43,306,000	19,878,000	19,492,000	27,914,000	32,259,000	28,092,000	22,352,000	21,345,000	28,426,000	29,696,000	30,947,000	26,945,000	23,589,000	20,760,000	13,311,000	12,859,000	7,103,000	5,334,000	2,945,000	2,935,000	2,878,000	3,618,000	3,455,000	4,185,000	2,076,000	4,785,000	6,983,000	5,741,000	5,476,000	6,105,000	3,152,000	4,689,000	1,308,000	2,293,000
total current assets	649,882,000	628,334,000	606,819,000	573,061,000	595,399,000	650,216,000	701,839,000	687,932,000	724,981,000	717,511,000	706,495,000	683,821,000	689,098,000	686,520,000	719,124,000	772,619,000	878,727,000	963,033,000	995,983,000	930,516,000	879,233,000	888,545,000	827,611,000	817,314,000	855,005,000	848,110,000	372,043,000	355,319,000	377,997,000	202,402,000	196,137,000	207,551,000	153,270,000	147,031,000	150,429,000	154,790,000	146,326,000	161,180,000	116,512,000	124,431,000	143,524,000	156,142,000	169,334,000	189,750,000	145,281,000	158,039,000	177,981,000	194,147,000	219,402,000	262,562,000	184,714,000	242,044,000	285,694,000	228,742,000	257,221,000	251,323,000	118,972,000	128,069,000	132,582,000	130,567,000	33,113,000	38,609,000	56,052,000	4,026	16,140	16,140	4,026	16,140	29,096	29,096	21,728	21,728	372	24,059	30,407	30,407	21,728	31,354	39,591											28,578	16,423
property, plant and equipment	12,000	13,000	14,000	15,000	16,000	24,000	49,000	81,000	114,000	147,000	179,000	187,000	874,000	999,000	1,137,000	1,281,000	1,425,000	1,569,000	1,713,000	1,862,000	2,016,000	2,166,000	2,316,000	2,466,000	2,361,000	2,124,000	858,000	57,000	63,000	69,000	17,000	20,000	28,000	39,000	52,000	69,000	78,000	102,000	137,000	172,000	243,000	266,000	296,000	339,000	381,000	424,000	472,000	523,000	579,000	646,000	706,000	766,000	811,000	796,000	621,000	492,000	432,000	73,000	65,000	73,000	88,000	119,000	128,000	464	595	595	464	595	527	527	595		6	635	643	643	595	632	314											1,530	960
long-term inventory		9,106,000	39,586,000	57,404,000	64,740,000	74,023,000	71,294,000	74,225,000	77,615,000	91,792,000	122,318,000	143,730,000	163,620,000	187,964,000	210,252,000	141,052,000	121,254,000
operating lease right-of-use asset	6,461,000	7,186,000	7,640,000	8,363,000	7,592,000	7,984,000	7,540,000	7,876,000	8,310,000	8,510,000	8,978,000	9,190,000	9,074,000	8,462,000	8,599,000	8,689,000	7,660,000	7,762,000	7,861,000	7,958,000	8,054,000	8,149,000	8,291,000	8,397,000	8,511,000	8,633,000	8,762,000	8,900,000
other long-term assets	1,055,000	1,109,000	1,135,000	1,174,000	1,213,000	1,250,000	1,287,000	1,324,000	1,360,000	1,395,000	1,604,000	1,638,000	458,000	456,000	456,000	456,000	456,000	456,000	456,000	456,000	432,000	1,074,000	1,074,000	1,074,000	1,074,000	1,074,000	1,102,000	643,000	174,000	174,000	174,000	174,000	174,000	174,000	173,000	652,000	741,000	682,000	174,000	174,000	2,045,000
intangible asset	13,365,000	14,066,000	14,932,000	15,660,000	16,389,000	17,118,000	17,846,000	18,575,000	19,304,000	19,676,000	20,377,000	21,078,000	21,780,000	21,638,000	22,274,000	22,911,000	23,547,000	24,183,000	24,820,000	25,456,000	13,817,000	14,177,000	14,538,000	14,898,000	15,258,000	6,996,000	7,157,000	7,319,000	7,480,000	7,642,000	7,803,000	7,964,000	8,126,000	8,287,000	8,449,000	8,610,000	8,772,000	8,933,000	9,095,000	9,256,000	9,417,000	9,579,000	9,740,000	9,902,000	10,063,000	10,225,000	10,386,000	10,548,000	10,709,000	10,870,000	11,032,000	11,193,000	11,355,000
total assets	670,775,000	659,814,000	670,126,000	655,677,000	685,349,000	750,615,000	799,855,000	790,013,000	831,684,000	839,031,000	860,018,000	860,188,000	886,179,000	908,303,000	973,237,000	973,709,000	1,068,065,000	1,035,805,000	1,044,991,000	990,252,000	966,021,000	960,203,000	914,869,000	925,668,000	882,209,000	866,937,000	389,922,000	372,238,000	385,714,000	210,287,000	204,131,000	215,709,000	161,598,000	166,613,000	170,185,000	175,203,000	166,999,000	193,903,000	147,636,000	152,712,000	173,462,000	182,422,000	195,165,000	215,339,000	171,107,000	185,373,000	205,839,000	220,207,000	252,476,000	293,846,000	214,667,000	271,331,000	310,855,000	254,998,000	271,175,000	260,840,000	126,379,000	131,670,000	135,520,000	132,806,000	35,367,000	38,744,000	56,197,000	25,876	36,657	36,657	25,876	36,657	49,550	49,550	42,254	42,254	396	24,716	31,074	31,074	42,254	41,486	49,559			46,760,000		23,721,000						62,486	32,502
liabilities and stockholders’ equity
current liabilities:
accounts payable	45,355,000	36,712,000	44,711,000	45,661,000	40,366,000	40,507,000	54,383,000	67,600,000	52,762,000	53,362,000	54,309,000	58,779,000	64,602,000	93,157,000	116,312,000	90,753,000	114,922,000	72,415,000	141,251,000	94,262,000	105,876,000	121,366,000	86,757,000	98,330,000	49,950,000	42,042,000	34,018,000	26,776,000	37,632,000	26,174,000	34,471,000	31,877,000	25,155,000	15,805,000	16,455,000	15,117,000	6,062,000	6,864,000	14,811,000	15,137,000	10,832,000	17,899,000	13,006,000	10,756,000	8,525,000	6,059,000	5,543,000	4,823,000	6,375,000	6,233,000	9,688,000	22,945,000	17,458,000	13,696,000	8,429,000	4,568,000	4,419,000	3,836,000	1,930,000	1,513,000	4,449,000																													2,075	1,226
accrued expenses and other current liabilities	149,104,000	145,521,000	141,235,000	116,747,000	139,583,000	161,047,000	176,159,000	154,440,000	204,174,000	211,304,000	214,598,000	183,264,000	192,678,000	192,001,000	243,064,000	207,622,000	253,111,000	289,684,000	226,545,000	228,734,000	198,641,000	189,650,000	168,549,000	170,731,000	139,826,000	134,542,000	103,495,000	94,170,000	84,171,000	93,899,000	73,753,000	61,311,000	58,902,000	51,627,000	49,102,000	44,434,000	37,720,000	38,334,000	31,052,000	24,551,000	24,226,000	22,503,000	21,004,000	17,675,000	16,268,000	15,365,000	13,205,000		9,594,000
total current liabilities	194,459,000	182,233,000	185,946,000	162,408,000	179,949,000	201,554,000	230,542,000	224,381,000	259,277,000	266,691,000	270,932,000	244,242,000	259,479,000	287,356,000	361,574,000	300,573,000	370,682,000	364,745,000	370,439,000	325,769,000	307,443,000	326,189,000	283,467,000	310,327,000	242,248,000	229,712,000	184,885,000	161,804,000	157,263,000	151,642,000	137,637,000	119,230,000	108,530,000	90,070,000	86,292,000	77,944,000	76,249,000	75,114,000	77,851,000	53,587,000	50,723,000	55,320,000	50,271,000	42,533,000	40,306,000	35,335,000	37,930,000	31,362,000	37,540,000	31,299,000	35,434,000	42,391,000	25,202,000	32,512,000	17,499,000	9,584,000	8,452,000	6,428,000	3,773,000	3,920,000	7,577,000	5,876,000	6,693,000	9,752	7,108	7,108	9,752	7,108	8,553	8,553	15,412	15,412	215	8,469	10,243	10,243	15,412	10,202												36,902	3,037
long-term liabilities:
long-term operating lease liability	6,080,000	6,731,000	7,338,000	7,940,000	7,723,000	8,215,000	8,099,000	8,389,000	8,737,000	8,970,000	9,472,000	9,841,000	10,015,000	9,924,000	10,174,000	10,398,000	8,576,000	8,729,000	8,875,000	9,015,000	9,153,000	9,255,000	9,311,000	9,381,000	9,443,000	9,432,000	8,160,000	7,930,000
other long-term liabilities	10,955,000	11,956,000	11,918,000	11,642,000	11,501,000	9,471,000	9,335,000	9,199,000	9,064,000	7,273,000	7,155,000	8,610,000	8,205,000	9,697,000	7,636,000	7,490,000	7,648,000	5,350,000	5,528,000	5,660,000	6,214,000	4,303,000	4,821,000	2,665,000	3,751,000	5,402,000	6,813,000	8,030,000	10,523,000	8,652,000	6,764,000	1,150,000	1,150,000	1,158,000	1,158,000	1,167,000	710,000	731,000	268,000	300,000	335,000	608,000	626,000	631,000	386,000	640,000	619,000	632,000	658,000	811,000	795,000			702,000	704,000
total liabilities	211,494,000	200,920,000	205,202,000	181,990,000	199,173,000	219,240,000	247,976,000	244,077,000	279,587,000	285,883,000	290,890,000	275,395,000	290,846,000	320,476,000	393,194,000	332,600,000	400,966,000	393,310,000	399,667,000	355,641,000	338,516,000	352,946,000	312,106,000	339,892,000	273,946,000	271,041,000	240,835,000	231,367,000	233,384,000	263,113,000	250,818,000	232,366,000	226,698,000	212,722,000	208,949,000	203,972,000	176,057,000	178,726,000	312,052,000	308,848,000	302,653,000	293,513,000	286,517,000	277,163,000	259,555,000	254,614,000	255,816,000	277,801,000	286,332,000	311,543,000	309,001,000	331,417,000	314,852,000	254,960,000	265,855,000	325,254,000	132,341,000	162,005,000	290,235,000	179,255,000	237,734,000	6,141,000	7,595,000	11,852	7,759	7,759	11,852	7,759	10,450	10,450	18,105	18,105		8,554	10,335	10,335	18,105	10,382	10,756											42,114	11,656
commitments and contingencies
stockholders’ equity:
ordinary shares, £0.50 par, unlimited authorized; 429,847,579 shares issued, 416,214,102 shares outstanding at december 31, 2025; 422,256,900 shares issued, 411,584,851 shares outstanding at december 31, 2024	310,184,000
additional paid-in capital	1,923,801,000	1,922,351,000	1,920,993,000	1,916,223,000	1,914,750,000	1,911,445,000	1,906,903,000	1,902,698,000	1,899,456,000	1,895,155,000	1,891,957,000	1,890,496,000	1,885,352,000	1,878,923,000	1,869,770,000	1,861,017,000	1,855,246,000	1,845,103,000	1,834,548,000	1,831,388,000	1,817,649,000	1,799,069,000	1,787,492,000	1,774,671,000	1,764,317,000	1,745,946,000	1,311,965,000	1,301,389,000	1,282,762,000	1,057,408,000	1,040,743,000	1,036,697,000	977,866,000	974,343,000	970,797,000	967,073,000	964,914,000	961,691,000	822,013,000	818,591,000	816,171,000	812,409,000	802,846,000	769,533,000	738,890,000	738,440,000	733,113,000	740,819,000	738,754,000	739,524,000	630,565,000	625,086,000	619,266,000	613,087,000	593,341,000	478,757,000	449,393,000	443,399,000	417,413,000	329,186,000	206,718,000
treasury stock	-67,360,000	-67,356,000	-67,108,000	-66,445,000	-65,326,000	-65,344,000	-65,276,000	-65,188,000	-63,752,000	-63,743,000	-63,464,000	-63,277,000	-61,770,000	-61,585,000	-61,419,000	-61,261,000	-60,726,000	-59,602,000	-59,011,000	-58,334,000	-51,082,000	-50,728,000	-50,252,000	-49,731,000	-35,900,000	-20,533,000	-20,533,000	-19,493,000	-10,413,000	-9,867,000	-6,909,000	-6,782,000	-4,229,000	-4,054,000	-3,902,000	-3,726,000	-1,498,000	-1,350,000	-1,197,000	-1,105,000	-411,000	-368,000	-334,000	-334,000	-217,000	-217,000	-217,000	-217,000	-217,000	-217,000	-217,000	-217,000	-217,000	-217,000	-217,000	-217,000	-217,000	-217,000	-217,000	-217,000	-217,000
accumulated deficit	-1,707,344,000	-1,706,120,000	-1,698,382,000	-1,684,243,000	-1,668,546,000	-1,619,928,000	-1,594,794,000	-1,596,316,000	-1,586,363,000	-1,580,582,000	-1,561,271,000	-1,543,711,000	-1,527,251,000	-1,528,107,000	-1,522,967,000	-1,453,011,000	-1,421,448,000	-1,436,146,000	-1,422,995,000	-1,430,803,000	-1,429,177,000	-1,434,103,000	-1,427,315,000	-1,431,730,000	-1,411,177,000	-1,418,245,000	-1,414,783,000	-1,412,963,000	-1,388,532,000	-1,354,863,000	-1,330,392,000	-1,296,182,000	-1,271,869,000	-1,249,404,000	-1,238,579,000	-1,224,945,000	-1,204,004,000	-1,176,551,000	-1,160,779,000	-1,149,064,000	-1,119,293,000	-1,097,402,000	-1,065,081,000	-1,002,228,000	-970,234,000	-950,577,000	-924,527,000	-939,850,000	-913,870,000	-898,459,000	-849,575,000	-809,801,000	-747,643,000	-737,076,000	-710,648,000	-656,744,000	-568,459,000	-586,797,000	-683,142,000	-481,039,000	-499,333,000																													-28,549	-25,133
total stockholders’ equity	459,281,000	458,894,000	464,924,000	473,687,000	486,176,000	531,375,000	551,879,000	545,936,000	552,097,000	553,148,000	569,128,000	584,793,000	595,333,000	587,827,000	580,043,000	641,109,000	667,099,000	642,495,000	645,324,000	634,611,000	627,505,000	607,257,000	602,763,000	585,776,000	608,263,000	595,896,000	149,087,000	140,871,000	152,330,000									15,177,000																38,000	5,320,000
total liabilities and stockholders’ equity	670,775,000	659,814,000	670,126,000	655,677,000	685,349,000	750,615,000	799,855,000	790,013,000	831,684,000	839,031,000	860,018,000	860,188,000	886,179,000	908,303,000	973,237,000	973,709,000	1,068,065,000	1,035,805,000	1,044,991,000	990,252,000	966,021,000	960,203,000	914,869,000	925,668,000	882,209,000	866,937,000	389,922,000	372,238,000	385,714,000									193,903,000																254,998,000	271,175,000
ordinary shares, £0.50 par value per share, unlimited authorized; 429,597,419 shares issued, 415,965,977 shares outstanding as of september 30, 2025; 422,256,900 shares issued, 411,584,851 shares outstanding as of december 31, 2024		310,019,000
ordinary shares, £0.50 par value per share, unlimited authorized; 428,714,819 shares issued, 415,401,497 shares outstanding as of june 30, 2025; 422,256,900 shares issued, 411,584,851 shares outstanding as of december 31, 2024			309,421,000
ordinary shares, £0.50 par value per share, unlimited authorized; 426,842,579 shares issued, 414,365,189 shares outstanding as of march 31, 2025; 422,256,900 shares issued, 411,584,851 shares outstanding as of december 31, 2024				308,152,000
current deferred revenue								2,341,000	2,341,000	2,025,000	2,025,000	2,199,000	2,199,000	2,198,000	2,198,000	2,198,000	2,649,000	2,646,000	2,643,000	2,773,000	2,926,000
long-term deferred revenue								2,108,000	2,509,000	2,949,000	3,331,000	12,702,000	13,147,000	13,499,000	13,810,000	14,139,000	14,060,000	14,486,000	14,825,000	15,197,000	15,706,000
common stock					305,298,000	305,202,000	305,046,000	304,742,000	302,756,000	302,318,000	301,906,000	301,285,000	299,002,000	298,596,000	294,659,000	294,364,000	294,027,000	293,140,000	292,782,000	292,360,000	290,115,000	287,585,000	285,672,000	270,716,000	269,173,000	266,878,000	250,588,000	250,088,000	246,663,000	232,646,000	225,507,000	225,246,000	208,768,000	208,642,000	208,556,000	208,465,000	207,166,000	207,023,000	151,183,000	151,078,000	149,978,000	149,906,000	149,842,000	145,026,000	143,113,000	143,113,000	141,654,000	141,654,000	141,477,000	141,455,000	124,893,000	124,846,000	124,597,000	124,244,000	122,844,000	113,790,000	113,321,000	113,280,000	111,231,000	105,621,000	90,465,000
long-term investments											67,000	544,000	1,275,000	2,264,000	11,395,000	26,701,000	34,996,000	38,802,000	14,158,000	24,004,000	62,469,000	46,092,000	61,039,000	81,519,000
debt from royalty-bearing instrument																						9,467,000	22,455,000	36,978,000
series a convertible preferred stock, £0.05 par, unlimited authorized; nil shares issued and nil outstanding at december 31, 2020 and 289,317,460 shares issued and outstanding at december 31, 2019
deferred revenue, current																						5,706,000	5,706,000	4,288,000	2,342,000	1,962,000	1,962,000	1,898,000	1,220,000	1,220,000	1,056,000	1,453,000	1,644,000	2,222,000	1,447,000	1,197,000	1,172,000	1,172,000	1,172,000	1,172,000	923,000	923,000	856,000
deferred revenue, long-term																						13,199,000	14,507,000	17,519,000	18,504,000	17,617,000	17,775,000	18,265,000	19,490,000	19,736,000	17,750,000	17,459,000	17,192,000	16,997,000	13,332,000	13,625,000	13,943,000	14,236,000	14,529,000	14,822,000	13,308,000	13,538,000	13,769,000
series a convertible preferred stock, £0.05 par, unlimited authorized; 23,850,780 shares issued and outstanding as of september 30, 2020																						5,434,000
series a convertible preferred stock, £0.05 par, unlimited authorized; 51,603,780 shares issued and outstanding as of june 30, 2020																							7,166,000
series a convertible preferred stock, £0.05 par, unlimited authorized; 289,317,460 shares issued and outstanding as of march 31, 2020 and december 31, 2019																								21,850,000
current portion of long-term debt from royalty-bearing instrument																									50,130,000	51,166,000	45,410,000	38,960,000	34,240,000	30,130,000	27,876,000	24,370,000	22,348,000	20,197,000	18,833,000	17,004,000	15,944,000	13,471,000
long-term debt from royalty-bearing instrument																										8,878,000	23,202,000	35,338,000	46,108,000	53,924,000	59,564,000	65,480,000	70,834,000	75,559,000	79,283,000	82,405,000	85,155,000	88,645,000
series a convertible preferred stock, £0.05 par, unlimited authorized; 289,317,460 shares issued and outstanding as of december 31, 2019 and december 31, 2018																									21,850,000
series a convertible preferred stock, £0.05 par, unlimited authorized; 289,317,460 shares issued and outstanding as of september 30, 2019 and december 31, 2018																										21,850,000
series a convertible preferred stock, £0.05 par, unlimited authorized; 289,317,460 shares issued and outstanding as of june 30, 2019 and december 31, 2018																											21,850,000
series a convertible preferred stock, £0.05 par, unlimited authorized; 289,317,460 shares issued and outstanding as of march 31, 2019 and december 31, 2018																												21,850,000
current portion of exchangeable senior notes, net of discount																														219,000	481,000	219,000	481,000	219,000	455,000	192,000	15,351,000	15,273,000
exchangeable senior notes, net of discount																														29,159,000	29,103,000	29,047,000	28,992,000	28,938,000	28,884,000	28,831,000			125,644,000	138,703,000	138,605,000	126,108,000	124,629,000	123,192,000	121,846,000
stockholders’ equity
series a convertible preferred stock, £0.05 par, unlimited authorized; 289,317,460 shares issued and outstanding as of december 31, 2018																													21,850,000
other receivables																														25,654,000
liabilities and stockholders’ deficit
stockholders’ deficit:
series a convertible preferred stock, £0.05 par, unlimited authorized; 289,317,460 shares issued and outstanding as of september 30, 2018																														21,850,000
total stockholders’ deficit																														-52,826,000	-46,687,000	-16,657,000	-65,100,000	-46,109,000	-38,764,000	-28,769,000	-9,058,000		-164,416,000	-156,136,000	-129,191,000	-111,091,000	-91,352,000	-61,824,000	-88,448,000	-69,241,000	-49,977,000	-57,594,000	-33,856,000	-17,697,000	-94,334,000	-60,086,000	-3,997,000			-64,414,000	-5,962,000	-30,335,000
total liabilities and stockholders’ deficit																														210,287,000	204,131,000	215,709,000	161,598,000	166,613,000	170,185,000	175,203,000	166,999,000		147,636,000	152,712,000	173,462,000	182,422,000	195,165,000	215,339,000	171,107,000	185,373,000	205,839,000	220,207,000	252,476,000	293,846,000	214,667,000	271,331,000	310,855,000			260,840,000	126,379,000	131,670,000
series a convertible preferred stock, £0.05 par, unlimited authorized; 328,184,640 shares issued and outstanding as of june 30, 2018 and december 31, 2017																															24,364,000
series a convertible preferred stock, £0.05 par, unlimited authorized; 328,184,640 shares issued and outstanding as of march 31, 2018 and december 31, 2017																																24,364,000
deferred tax assets																																		11,082,000	11,082,000	11,082,000	11,082,000	23,006,000	21,718,000	18,679,000		934,000	934,000	934,000	934,000	471,000	471,000		471,000
series a convertible preferred stock, £0.05 par, unlimited authorized; 328,184,640 shares issued and outstanding as of december 31, 2017 and december 31, 2016																																	24,364,000
series a convertible preferred stock, £0.05 par, unlimited authorized; 328,184,640 shares issued and outstanding as of september 30, 2017 and december 31, 2016																																		24,364,000
series a convertible preferred stock, £0.05 par, unlimited authorized; 328,184,640 shares issued and outstanding as of june 30, 2017 and december 31, 2016																																			24,364,000
series a convertible preferred stock, £0.05 par, unlimited authorized; 328,184,640 shares issued and outstanding as of march 31, 2017 and december 31, 2016																																				24,364,000
long-term debt derivative liabilities																																							3,610,000	9,420,000	8,170,000	6,930,000	6,700,000	6,100,000	7,400,000	9,000,000	9,400,000
series a convertible preferred stock, £0.05 par, unlimited authorized; 328,184,640 issued and outstanding as of december 31, 2016 and 2015																																					24,364,000
series a convertible preferred stock, £0.05 par, unlimited authorized; 328,184,640 shares issued and outstanding as of september 30, 2016 and december 31, 2015																																						24,364,000
current portion of long-term debt																																							30,816,000	12,727,000	14,742,000	13,995,000	15,405,000	14,102,000	15,394,000	13,790,000
long-term debt																																							90,150,000	92,016,000	91,512,000	91,009,000	90,522,000	90,082,000	89,617,000	89,152,000	88,700,000	88,207,000	87,717,000	87,319,000	86,687,000																																								419
series a convertible preferred stock, £0.05 par, unlimited authorized; 328,184,640 shares issued and outstanding as of june 30, 2016 and december 31, 2015																																							24,364,000
series a convertible preferred stock, £0.05 par, unlimited authorized; 328,184,640 shares issued and outstanding as of march 31, 2016 and december 31, 2015																																								24,364,000
deferred tax assets, current
deferred tax assets, long-term																																									18,233,000
series a convertible preferred stock, £0.05 par, unlimited authorized; 328,184,640 issued and outstanding as of december 31, 2015 (equivalent to 32,818,464 ordinary shares upon future consolidation and redesignation at a 10:1 ratio); zero shares issued and outstanding as of december 31, 2014																																									24,364,000
other non-current assets																																										2,297,000	2,508,000	2,697,000	2,826,000	4,823,000	5,063,000	3,021,000	4,360,000	5,335,000	5,335,000	5,335,000	4,951,000					3,528,000	2,873,000														18
series a convertible preferred stock, £0.05 par, unlimited authorized; 328,184,640 issued and outstanding as of september 30, 2015 (equivalent to 32,818,464 ordinary shares upon future consolidation and redesignation at a 10:1 ratio); zero shares issued and outstanding as of december 31, 2014																																										24,364,000
series a convertible preferred stock, £0.05 par, unlimited authorized; 289,317,460 issued and outstanding as of june 30, 2015 (equivalent to 28,931,746 ordinary shares upon future consolidation and redesignation at a 10:1 ratio); zero shares issued and outstanding as of december 31, 2014																																											21,375,000
deferred revenue																																												14,625,000					1,703,000	1,617,000	1,833,000	2,865,000
series a convertible preferred stock, £0.05 par, unlimited authorized; 352,150,790 issued and outstanding at march 31, 2015 (equivalent to 35,215,079 ordinary shares upon future consolidation and redesignation at a 10:1 ratio); zero shares issued and outstanding at december 31, 2014																																												26,179,000
inventory, current																																													13,733,000	11,886,000	17,143,000	21,830,000	21,209,000
other current assets																																													2,633,000	2,980,000	2,875,000	2,943,000	1,563,000	3,537,000	2,171,000	7,051,000	3,253,000	4,110,000	6,433,000	4,968,000	1,837,000	2,214,000	1,136,000	1,085,000	1,063,000	446,000	2,602,000	1,165	1,227	1,227	1,165	1,227	1,500	1,500	1,721	1,721	174	1,753	1,434	1,434	1,721	1,216	1,172
inventory, long-term
warrant derivative liability																																													119,000	121,000	4,513,000	5,929,000		39,598,000	36,028,000	49,011,000	54,854,000	90,963,000	120,214,000	191,387,000	123,125,000	155,018,000	285,984,000	174,819,000	230,069,000
exchangeable senior notes																																														120,487,000	119,167,000	150,000,000	149,317,000	145,316,000	141,457,000	137,735,000	134,250,000
accrued interest payable																																															14,669,000	12,569,000	12,974,000	10,901,000	9,555,000	4,646,000	2,520,000
deferred tax asset																																																471,000		936,000	936,000	937,000	937,000	533,000	533,000	533,000	533,000			2,166,000	608,000
accrued expenses and other liabilities																																																8,041,000		12,548,000	14,358,000	11,935,000	5,224,000	18,816,000	9,070,000	5,016,000	4,033,000	2,592,000	1,843,000	2,407,000	3,128,000	1,769,000	3,838,000	2,828	3,782		2,828	3,782		4,578		6,733	109		7,919	7,919			8,660
long-term debt redemption feature																																																7,600,000	11,100,000	7,200,000	8,600,000
inventory, long term																																																	5,482,000
warrant derivative liability, current																																																	6,894,000
warrant derivative liability, long-term
long- term debt																																																				85,873,000
long- term debt redemption feature																																																				15,600,000
other long term liabilities																																																				807,000	816,000
long term debt																																																					85,153,000	130,783,000	127,438,000
long term debt redemption feature																																																					14,577,000
other long term assets																																																						15,672,000	2,482,000	1,657,000	2,241,000
liabilities and stockholders’ (deficit) equity
long term debt and other long-term liabilities																																																								124,283,000
lease obligations and other long-term liabilities																																																									764,000	559,000	478,000	516,000	88,000
liabilities and stockholders’
stockholders’
total stockholders’																																																											-154,715,000	-46,449,000
total liabilities and stockholders’																																																											135,520,000	132,806,000
revenues
operating expenses:
research and development																																																											5,189,000	4,449,000
marketing, general and administrative																																																											10,025,000	2,726,000
total operating expenses																																																											15,214,000	7,175,000
operating income																																																											15,214,000	-7,175,000
loss on change in fair value of derivative liability																																																											185,359,000
interest income																																																											-94,000	1,000
other income																																																											-11,000	77,000
income from operations before taxes																																																											200,468,000	18,245,000
benefit from income taxes																																																											1,635,000
net and comprehensive loss																																																											202,103,000
loss per share:
basic and diluted																																																											1,580
weighted-average shares:
gain on change in fair value of derivative liability																																																												25,342,000
benefit for income taxes																																																												49,000
net and comprehensive income																																																												18,294,000
income per share:
basic																																																												150
diluted																																																												120
stockholders’ (deficit) equity:
total stockholders’ (deficit) equity																																																													-202,367,000
total liabilities and stockholders’ (deficit) equity																																																													35,367,000
non-current assets
investment available for sale																																																														16,000
total non-current assets																																																														135,000	145,000	21,850	20,517		21,850	20,517		20,454		20,526	24		667	667			9,968
current assets
current tax recoverable																																																														418,000	1,192,000	1,226	674		1,226	674		1,256		1,704			1,363	1,363			1,617
equity																																																																																								2,982	-10,062
capital and reserves attributable to owners of the parent
share capital																																																														84,698,000	83,930,000	25,928	25,928	25,928	25,928	25,928	25,928	25,928	12,942		7	8,691	8,691	8,691	12,942	7,991	7,990
share premium																																																														189,063,000	188,337,000	152,864	152,273		152,864	152,273		152,378		147,171	9,224		139,938	139,938			139,313
share based payment reserve																																																														24,623,000	22,793,000	21,118	19,564		21,118	19,564		16,877		10,175	543		7,419	7,419			4,824
capital redemption reserve																																																														27,633,000	27,633,000	27,633	27,633		27,633	27,633		27,633		27,633			27,633	27,633			27,633	27,633	27,633		27,633		27,634
treasury shares																																																														-217,000		-217	-217		-217	-217		-217		-217			-217	-217			-217	-217	-217		-217
foreign currency translation adjustment																																																														-2,764,000		-2,254			-2,254			-1,719					-1,926	-1,926			-1,261
retained deficit																																																														-290,433,000
total shareholders’ equity																																																														32,603,000	48,602,000	14,024	28,898		14,024	28,898		39,100		24,149			20,739	20,739														20,372	20,846
liabilities
non-current liabilities
provisions																																																														260,000	890,000	614	627	627	614	627	374	374	606	606					606	81	119
other liabilities																																																														5,000	12,000	28	24	24	28	24	30	30	36	36		85	92	92	36	99	116
total non-current liabilities																																																														265,000	902,000	2,100	651	651	2,100	651	1,897	1,897	2,693	2,693	19	85	92	92	2,693	180	235
current liabilities
trade payables																																																														3,801,000	2,457,000	1,627	1,955	1,955	1,627	1,955	1,604	1,604	3,462	3,462	106	1,832	2,324	2,324	3,462	1,435	2,096
total shareholders’ equity & liabilities																																																														38,744,000
intangible assets																																																																21,374	19,916		21,374	19,916	19,916	19,916		19,916							9,636	8,953	9,290		9,965		3,755			44,747	29,477
available for sale investment																																																															17,000	12		6	12		11	11	15			22	24	24	15	20	18
cash on short term deposits
cash																																																															52,258,000			14,239			26,340		18,303			20,735			18,303	28,969												20,688	1,348
capital and reserves attributable to owners of the parent holders of the company
equity component of 8% convertible debt																																																																						145		145
retained earnings																																																																-220,326	-203,766		-220,326	-203,766		-191,843		-185,192			-171,419	-171,419			-149,723
borrowings																																																																1,439			1,439
derivative financial liability																																																																						1,493
current derivative financial liabilities																																																																3,565			3,565
total shareholders’ equity and liabilities																																																															56,197,000	25,876	36,657		25,876	36,657		49,550		42,254
capital and reserves attributable to equity holders of the company
warrant reserve																																																																9,278	9,918		9,278	9,918		9,918		13,328			10,614	10,614			10,009
financial liability																																																																1,458			1,458		1,493
investments in subsidiaries
available for sale investments																																																																	6			6				15
cash on short-term deposits																																																																	3,000			3,000
other current derivative financial liabilities																																																																	1,037			1,037		1,910
foreign currency translation reserve																																																																	-2,435			-2,435				-1,836
selected balance sheet data
intangible fixed assets																																																																		19,916					19,916						19,916	9,480
income tax recoverable																																																																		674			1,256		1,704			1,571			1,704	1,169
convertible debt																																																																							2,051						2,051
accrued expenses & other liabilities																																																																		4,819			6,488		6,733			6,637			6,733	8,767
capital and reserves attributable to equity holders
other reserves																																																																		2,970			13,172		11,207			7,471			11,207	23,113
total shareholders' equity and liabilities																																																																		36,657			49,550		42,254			24,716	31,074	31,074	42,254	41,486	49,559
1. selected balance sheet data
non-current assets - sum																																																																					20,454		20,526
2. the selected financial data set out in this press release should be read in conjunction with our 2007 ifrs annual report on form 20-f which was filed with the sec on may 19, 2008.
3. loss per share
effective january 18, 2008 our ordinary shares were consolidated on a one-for-ten basis whereby ten ordinary shares of 5p each became one ordinary share of 50p. shares and share related information (such as loss per share information) reflect this one-for-ten ordinary share consolidation.
4. non-current assets - intangible assets
intangible assets of 19,916,000 relate to the acquisition of ester neurosciences limited on december 5, 2007 representing the upfront acquisition consideration already satisfied in cash and shares in december 2007 plus 4,756,000 of a provision relating to a future contingent milestone, likely payable during 2008. this milestone is payable in cash or shares, at amarin’s option (see note 6 below).
5. non-current liabilities – convertible debt
in december 2007, the company issued 2.75 million 8% convertible notes. these notes are being repaid out of the proceeds of the first tranche of the funding announced on may 14, 2008.the difference between the carrying amount of the liability component at the date of issue and the amount reported in the balance sheet at december 31, 2007 represents the change in amortized cost under the effective interest rate method.
6. current liabilities – provisions
included in provisions is 4,756,000 which relates to the fair value of the contingent consideration payable to former ester shareholders in cash or shares, at amarin’s option, on the achievement of a certain milestone as a result of the acquisition of ester neurosciences limited on december 5, 2007. the achievement of this milestone is considered to be probable and is recognized as a liability.
7. basis of preparation
as at december 31, 2007, the company had cash balances of 18,303,000. as previously announced, on may 14, 2008, amarin announced a private placement of ordinary shares for up to 60 million to be funded in two equal tranches. amarin expects to announce the closing of the first tranche shortly. the investors in this funding have an option to fund up to 30 million in the second tranche upon completion of certain business milestones by the company. amarin now forecasts having sufficient cash to fund operations for at least the next 12 months. the directors of the company believe it is appropriate to prepare the financial statements on a going concern basis. the basis of preparation assumes that the company will continue in operational existence for the foreseeable future.
non-current assets property, plant and equipment																																																																								595
current assets inventory
non-current liabilities borrowings																																																																								2,051
equity capital and reserves attributable to equity holders of the company share capital																																																																								12,942
assets non-current assets
other non-current liabilities																																																																									19
retained losses																																																																									-9,612
total equity																																																																									162
total equity and liabilities																																																																									396
2. the selected financial data set out in this press release should be read in conjunction with our 2006 20-f which was filed with the sec on march 5, 2007 and our 2006 statutory annual report (including risk factors described therein) which was furnished on a form 6-k to the sec on may 9, 2007 and our ifrs transition document also furnished on a form 6-k to the sec on may 9, 2007.
3. loss per share basic loss per share is calculated by dividing the net income by the weighted-average number of shares in issue in the period. the company reported a net income in the three months ended september 30, 2006 and 2007. as a result the loss per share is not reduced by dilution from outstanding options and warrants.
4. going concern basis as at september 30, 2007, amarin had cash of 20.7 million compared to 36.8 million at december 31, 2006. amarin has no debt other than working capital liabilities and based on current business activities forecasts having sufficient cash to fund the group’s operating activities into september 2008.
amarin intends to obtain additional funding through earning licensing fees from its partnering activities and/or completing further financings. there is no assurance that amarin’s efforts to raise additional funding will be successful. if efforts are unsuccessful, there is uncertainty as to whether amarin will be able to fund its business through the third quarter of 2008 and beyond.
these selected data do not include any adjustments that might be necessary should such funding not be available. amarin believes it will be successful in obtaining further funds as described above and the directors have therefore presented the selected data on a going concern basis.
shareholders’ equity
fair value investment reserve																																																																											6	6
2. the selected financial data set out in this press release should be read in conjunction with our 2006 annual report on form 20-f, which was filed with the sec on march 5, 2007, our 2006 statutory annual report (including risk factors described therein), which was furnished to the sec on form 6-k on may 9, 2007, and our ifrs transition document also furnished to the sec on form 6-k on may 9, 2007. 3. intangible assets on april 24, 2007, amarin announced the results from its phase iii clinical trials of miraxion to treat hd, which showed no statistically significant difference in either study between miraxion and placebo with regard to primary and secondary endpoints. at march 31, 2007, the valuation model for miraxion, which incorporated appropriate industry-based risk factors, continued to show that the fair value of miraxion was in excess of its book value of 9.5 million and, on that basis, no impairment write down is recognised in respect of the intangible asset at march 31, 2007. while miraxion may have potential value in central nervous system disorders and other therapeutic indications, due to the results of the phase iii trials, at this stage, amarin has determined that it is appropriate to write off the intangible asset, all of which relates to miraxion. this is a non-adjusting event for the first quarter. the non-cash write off will occur in the second quarter of 2007 and will increase net income and reduce net assets of amarin by an amount equivalent to the intangible asset’s carrying value at the date of impairment, estimated to be 9.5 million.
derivative liability
total capital and reserves																																																																															38,568
fixed assets
tangible assets																																																																																282	198		421		261			2,305	1,482
investments																																																																																						158,171	158,171			44	10,064
stock																																																																																								6,331	4,799
debtors																																																																																2,789	2,251		2,135		913	524,601	587,604	3,696	9,694
cash at bank and in hand																																																																																36,802	28,815		16,382		7,211	149	307	11,232	15,072
creditors: amounts falling due within one year																																																																																-10,756	-6,852		-3,654					-30,973	41,557
net current assets/																																																																																28,835					5,225
total assets less current liabilities																																																																																38,070	33,702		25,249		9,241	5,558		37,338	18,967
creditors: amounts falling due after more than one year																																																																																-116	-137							-34,311	22,792
convertible loan note
provisions for liabilities and charges																																																																																-119	-85		-652					-45	31
net assets																																																																																37,835	33,480		24,597
capital and reserves
called up share capital																																																																																7,990	7,121		4,471		1,454	4,000,000	4,000,000	29,076	11,838
share premium account																																																																																146,859	130,654		102,644		70,223	5,000,000	5,000,000	71,015	37,981
profit and loss account																																																																																-144,430	-131,711		-109,934						-52,648
total equity shareholders’ funds																																																																																37,835
net current assets																																																																																	24,214		14,863
equity shareholders’ funds																																																																																	33,480		24,597			5,558
statement of operations data — uk gaap
net sales revenues																																																																																		500,000		1,017,000
total (loss) from operations																																																																																		-18,908,000
(loss) from continuing operations																																																																																		-18,908,000
net income																																																																																		-18,707,000		4,012,000
net income per ordinary share																																																																																		-400		210
amounts in accordance with us gaap
operating																																																																																		-19,527,000
net																																																																																		-19,630,000
weighted-average shares																																																																																		46,590,000		22,511,000
consolidated balance sheet data
amounts in accordance with uk gaap
working capital (liabilities)/assets																																																																																		28,673,000
long term obligations																																																																																		-180,000
capital stock																																																																																		6,778,000		3,206,000
total shareholders’ equity/																																																																																		38,580,000		16,693,000
number of ordinary shares in issue																																																																																		77,549,000		37,632,000
denomination of each ordinary share
number of £ 13% cumulative preference shares in issue
long term obligations/deferred credit																																																																																		-41,519,000
statement of operations data – uk gaap
total income from operations
working capital assets/																																																																																				8,651,000
number of £1 3% cumulative preference shares in issue
net assets/																																																																																					4,241			2,982
equity shareholders’ funds/																																																																																					4,241
tangible fixed assets
fixture and fittings																																																																																						129,537	117,629
office equipment																																																																																						12,203	5,091
creditors: amounts due within one year
net current(liabilities)/assets
net current liabilities																																																																																								-9,714
equity shareholders’ (deficit)/funds
unaudited
merger reserve																																																																																								-1,653	-1,027
profit and loss account — deficit																																																																																								-95,456
total shareholders’ funds/																																																																																								2,982
analysis of shareholders’ funds/
non-equity																																																																																									6,206
net current (liabilities)/assets																																																																																									-11,992
net (liabilities)/assets																																																																																									-3,856
total shareholders’ (deficit)/funds																																																																																									-3,856
analysis of shareholders’ (deficit)/funds
a s s e t s
accounts receivable from related parties																																																																																											50
inventories																																																																																										2,438	1,878
prepaid expenses																																																																																										448	227
intangibles																																																																																										32,378	15,119
l i a b i l i t i e s
short-term debt																																																																																										118
short-term debt owed to related parties																																																																																										30,919
current portion of finance leases and purchase contracts																																																																																										97	166
other current liabilities																																																																																										3,693	1,645
long-term debt owed to related parties																																																																																										4,466	5,847
finance leases and purchase contracts																																																																																											94
provision for deferred taxes
other long term creditors																																																																																										77	151
provision for restructuring																																																																																										669
s h a r e h o l d e r s ’ e q u i t y
ordinary shares of 10 pence par value 500,000,000 shares authorized, 76,743,893 (us11,169,000) issued and outstanding at december 31, 2001; 500,000,000 shares authorized, 68,145,760 (us10,180,000) issued and outstanding at december 31, 2000; and 500,000,000 authorized, 19,014,462 (us3,064,000) issued and outstanding at december 31, 1999																																																																																										7,674	6,814
3% cumulative convertible preference shares of 100 pence par value 5,000,000 shares authorized, 4,129,819 (us6,011,000) issued and outstanding at december 31, 2001; 5,000,000 shares authorized, 4,129,819 (us6,304,000) issued and outstanding at december 31, 2000; and 5,000,000 authorized, 4,129,819 (us6,656,000 issued and outstanding at december 31, 1999																																																																																										4,130	4,130
additional paid-in capital.																																																																																										38,144	36,062
merger and other reserves																																																																																										-1,027	-1,027
total liabilities and shareholders’ equity																																																																																										62,486	32,502
benefit from deferred taxes
benefit from restructuring																																																																																											2,108

Cashflow Statements:

Quarterly

Annual

Unit: USD	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31

cash flows from operating activities:
net loss	-44,609,000	-7,738,000	-14,139,000	-15,697,000	-48,618,000	-25,134,000	1,522,000	-9,953,000		-19,311,000	-17,560,000	-16,460,000								-1,626,000	4,926,000	-6,788,000	4,415,000	-20,553,000	7,068,000	-3,462,000	-1,820,000	-24,431,000	-33,669,000	-24,471,000	-34,210,000	-24,095,000						-15,772,000								-26,050,000	15,323,000	-25,980,000	-15,411,000	-48,884,000	-39,774,000	-62,158,000	-10,567,000	-26,428,000			18,338,000	96,345,000
adjustments to reconcile net loss to net cash from operating activities:
depreciation and amortization	95,000	1,000	1,000	1,000	8,000	25,000	32,000	33,000	33,000	33,000	31,000	63,000	125,000	138,000	144,000	144,000	144,000	144,000	149,000	150,000	151,000	150,000	150,000	146,000	127,000	47,000	0	6,000	11,000	1,000	3,000	8,000	11,000	13,000	17,000	21,000				44,000	41,000	40,000	43,000	42,000	43,000	48,000	51,000	56,000	67,000	60,000	60,000	59,000	57,000	48,000	43,000	32,000	28,000	16,000	17,000	15,000
accretion of investments	-2,710,000	-830,000	-973,000	-1,216,000		-1,418,000	-1,198,000	-1,547,000																-151,000
stock-based compensation	5,383,000	1,956,000	6,039,000	4,327,000	3,402,000	4,698,000	4,387,000	5,218,000	4,647,000	3,608,000	1,835,000	5,556,000	6,612,000	4,877,000	8,646,000	6,078,000	10,102,000	10,432,000	2,479,000	13,925,000	11,508,000	11,583,000	12,131,000	10,591,000	8,188,000	7,963,000	7,883,000	6,883,000	4,774,000	6,651,000	3,619,000	3,762,000	3,489,000	3,495,000	3,625,000	3,351,000	3,237,000	3,414,000	3,365,000	3,597,000	3,712,000	3,919,000	3,216,000	3,042,000	2,750,000	1,921,000	2,394,000	1,957,000	515,000	4,207,000	5,089,000	4,874,000	4,731,000	4,635,000	4,835,000	3,874,000	3,272,000	2,662,000	1,820,000	1,540,000
amortization of intangible asset	592,000	866,000	728,000	729,000	729,000	728,000	729,000	729,000	701,000	701,000	701,000	702,000	636,000	636,000	637,000	636,000	637,000	636,000	636,000	361,000	360,000	361,000	360,000	360,000	195,000	161,000	162,000	161,000	162,000	161,000	161,000	162,000	161,000	162,000	161,000	162,000	161,000	162,000	161,000	161,000	162,000	161,000	162,000	161,000	162,000	161,000	162,000	161,000	161,000	162,000	162,000	161,000
changes in assets and liabilities:
accounts receivable	16,314,000	-8,179,000	-12,396,000	15,545,000	-9,637,000	11,049,000	-7,885,000	17,757,000	-11,163,000	330,000	10,506,000	-2,246,000	-7,611,000	20,563,000	-33,708,000	53,419,000	-14,292,000	32,898,000	-30,984,000	3,299,000	-7,282,000	-22,307,000	33,303,000	-41,858,000	-12,847,000	-8,185,000	-15,913,000	-12,962,000	-18,875,000	2,661,000	-11,129,000	6,138,000	-10,708,000	2,865,000	-8,025,000	-9,465,000	-2,493,000	135,000	-2,620,000	-1,193,000	-2,587,000	-1,296,000	-1,398,000	-703,000	-1,175,000	-303,000	-2,339,000	-380,000	76,000	-1,454,000	1,174,000	-3,441,000
inventory	68,464,000	17,021,000	6,064,000	13,894,000	67,235,000	12,679,000	18,803,000	6,726,000	10,022,000	3,086,000	20,204,000	22,809,000	23,218,000	20,454,000	-27,154,000	-52,940,000	-46,662,000	-36,813,000	-41,563,000	-42,028,000	-40,333,000	-23,687,000	-32,723,000	-15,352,000	-22,212,000	-8,289,000	11,641,000	-107,000	-14,129,000	-3,580,000	-4,989,000	-4,844,000	-1,710,000	-3,736,000	-935,000	-3,372,000													392,000	1,431,000			-12,273,000
prepaid and other current assets	16,326,000	-12,021,000	7,338,000	-12,577,000	-5,405,000	24,405,000	-23,410,000	3,476,000	7,846,000	23,842,000	-23,428,000	-386,000	8,566,000	4,201,000	-4,167,000	-5,740,000	-1,006,000	7,080,000	1,270,000	1,251,000	-4,613,000	-2,750,000	-2,857,000	-7,416,000	-452,000	-5,756,000	-1,769,000	-2,389,000	-10,000	-57,000	740,000	-163,000	730,000	391,000	2,709,000	2,198,000	-1,242,000	-265,000	629,000	-2,953,000	1,537,000	-3,381,000	985,000	340,000
other long-term assets	43,000	26,000	39,000	39,000	37,000	37,000	37,000	36,000	35,000	209,000	34,000	-556,000					0	0	0	-24,000					0	28,000	-459,000	-469,000					0	-1,000	479,000	89,000
interest receivable	-519,000	29,000	-30,000	450,000	180,000	-249,000			44,000	100,000	120,000	-16,000	-142,000	254,000	89,000	140,000	15,000	51,000	554,000	118,000	403,000	-420,000	-291,000	-1,021,000
deferred revenue					0	0	-4,449,000	-401,000	-124,000	-382,000	-9,545,000	-445,000	-351,000	-311,000	-329,000	-372,000	-423,000	-336,000	-502,000	-662,000	-273,000	-1,308,000	-1,594,000	961,000	1,267,000	-158,000	-426,000	-547,000	-246,000	2,150,000	-106,000	-142,000	-383,000	1,940,000	-43,000	-293,000	-293,000	-293,000	-293,000	1,763,000	-230,000	-164,000	0	14,625,000	0	0	0	-1,703,000
accounts payable, accrued expenses and other current liabilities
other long-term liabilities	2,272,000	-115,000	397,000	-413,000	1,930,000	-192,000	182,000	221,000	1,758,000	84,000	-1,612,000	115,000	-2,014,000	1,948,000	12,000	635,000	2,248,000	-222,000	-177,000	-596,000	1,902,000	-432,000	2,192,000	-1,033,000	-1,518,000	-1,136,000	-817,000	-2,369,000	1,871,000	1,888,000			-8,000	0	-9,000	457,000
net cash from operating activities	-22,470,000	-12,697,000	16,606,000	-12,459,000	-13,310,000	-2,360,000	-2,749,000	-12,601,000	-645,000	7,329,000	7,204,000	-7,008,000	1,552,000	-18,213,000	-64,584,000	-98,847,000	-28,240,000	-4,540,000	-15,053,000	-18,704,000	-38,323,000	10,853,000	1,587,000	4,137,000	-8,936,000	21,750,000	15,909,000	-38,089,000	-32,303,000	-28,157,000	-24,438,000	-9,805,000	-2,140,000	-6,277,000	-10,503,000	-13,917,000	-19,311,000	-18,724,000	-8,969,000	-24,811,000	-24,648,000	-22,481,000	-24,976,000	-12,643,000	-13,624,000	-19,878,000	-11,313,000	-27,494,000	-33,081,000	-44,839,000	-52,781,000	-59,635,000	-43,764,000	-39,417,000	-21,385,000	-17,737,000	-11,576,000	-8,277,000	-10,777,000	-8,809,000
capital expenditures	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	-1,000	0	-251,000	-364,000	0	0	0	-5,000	0	0		0	0	0	-12,000	0	0	0	0	-18,000	0	0	0	0	0	0		0	0	0	-14,000	-72,000	-213,000	-172,000	-92,000	-365,000	0	0
free cash flows	-22,470,000	-12,697,000	16,606,000	-12,459,000	-13,310,000	-2,360,000	-2,749,000	-12,601,000	-645,000	7,329,000	7,204,000	-7,008,000	1,552,000	-18,213,000	-64,584,000	-98,847,000	-28,240,000	-4,540,000	-15,053,000		-38,323,000	10,852,000	1,587,000	3,886,000	-9,300,000	21,750,000	15,909,000	-38,089,000	-32,308,000	-28,157,000	-24,438,000		-2,140,000	-6,277,000	-10,503,000	-13,929,000	-19,311,000	-18,724,000	-8,969,000	-24,811,000	-24,666,000	-22,481,000	-24,976,000	-12,643,000	-13,624,000	-19,878,000	-11,313,000		-33,081,000	-44,839,000	-52,781,000	-59,649,000	-43,836,000	-39,630,000	-21,557,000	-17,829,000	-11,941,000	-8,277,000	-10,777,000
cash flows from investing activities:
maturities of securities	70,500,000	57,000,000	50,300,000	55,000,000	47,000,000	52,800,000	71,000,000	62,000,000	29,111,000	64,004,000	64,080,000	32,913,000		54,203,000	73,191,000	113,220,000
purchases of securities	-128,821,000	-69,129,000	-37,890,000	-42,936,000	-69,839,000	-109,351,000	-66,305,000	-33,281,000	-99,601,000	-33,236,000	-29,737,000	-52,523,000	-44,126,000	-23,335,000	-1,000	-14,171,000	-57,128,000	-158,557,000			-91,589,000	-59,632,000
investment in software and website development costs
purchases of furniture, fixtures and equipment																					0	-1,000	0	-251,000	-364,000
net cash from investing activities	-58,321,000	-12,129,000	12,410,000	12,064,000	-22,839,000	-56,551,000	4,695,000	28,719,000	-70,999,000	30,767,000	34,320,000	-19,610,000	-27,819,000	30,868,000	73,190,000	99,049,000	25,016,000	-99,491,000	50,649,000	127,929,000	23,686,000	-4,359,000	-102,468,000	-293,822,000	-364,000	-1,313,000			-5,000				0	0	0	-12,000	0	0	0	-21,000	-18,000								0	0	0	-14,000	-12,627,000	-626,000	-997,000	-92,000	-365,000
cash flows from financing activities:
proceeds from issuance of ordinary shares under employee stock purchase plan
proceeds from exercise of stock options					0	0	0	10,000
taxes related to stock-based awards
net cash from financing activities	587,000	-248,000	-663,000	-1,119,000	17,000	-68,000	34,000	-1,426,000	83,000	-277,000	60,000	364,000	38,000	-156,000	244,000	-505,000	-196,000	-110,000	426,000	-5,193,000	-5,606,000	-13,292,000	-14,154,000	-25,855,000	-19,316,000	433,400,000	-4,425,000	-47,000	200,543,000	7,845,000	-2,354,000	65,217,000	-3,309,000	-101,000	-109,000	11,754,000	0	63,795,000	97,000	-766,000	12,651,000	5,417,000	-169,000	54,299,000	-2,272,000	4,785,000	-2,437,000	258,000	-1,290,000	121,298,000	427,000	1,187,000	101,523,000	4,898,000	26,815,000	147,049,000	2,688,000	4,360,000	12,750,000	106,849,000
net increase in cash and cash equivalents and restricted cash	-80,204,000	-25,074,000	28,353,000	-1,514,000		-58,979,000	1,980,000	14,692,000	-71,561,000	37,819,000			-26,229,000	12,499,000	8,850,000	-303,000	-3,420,000	-104,141,000	36,022,000	104,032,000	-20,243,000				-28,616,000	453,837,000	10,683,000	-38,136,000	168,235,000	-20,365,000	-26,792,000	55,412,000
cash and cash equivalents and restricted cash, beginning of period	78,439,000	0	0	121,338,000	0	0	0	199,777,000	0	0	0	218,189,000	0	0	0	223,372,000	0	0	0	190,879,000	0	0	0	648,495,000	0	0	0	250,727,000	0	0	0	74,237,000
cash and cash equivalents and restricted cash, end of period	-1,765,000	-25,074,000	28,353,000	119,824,000	-36,132,000	-58,979,000	1,980,000	214,469,000	-71,561,000	37,819,000	41,584,000	191,935,000	-26,229,000	12,499,000	8,850,000	223,069,000	-3,420,000	-104,141,000	36,022,000	294,911,000	-20,243,000	-6,798,000	-115,035,000	332,955,000	-28,616,000	453,837,000	10,683,000	212,591,000	168,235,000	-20,365,000	-26,792,000	129,649,000
supplemental disclosure of cash flow information:
cash paid during the year for:
income taxes, net of refunds
supplemental disclosure of non-cash transactions:
initial recognition of operating lease right-of-use asset	213,000	0	-981,000	1,837,000	1,000	879,000	108,000	81,000	177,000	-150,000	134,000	446,000	893,000	96,000	16,000	1,036,000									0	0	0	8,995,000
initial recognition of furniture, fixtures and equipment lease									0	0	0	624,000
adjustments to reconcile loss to net cash from operating activities:
accounts payable and other current liabilities		-3,713,000	23,538,000	-17,541,000		-28,988,000	8,502,000	-34,896,000		-4,241,000	26,864,000	-15,237,000		-66,015,000	61,001,000	-69,658,000		-5,697,000	44,800,000	6,479,000		55,710,000	-13,755,000	79,285,000	10,951,000	40,197,000	17,003,000	-2,238,000	1,597,000	11,859,000	15,023,000	9,123,000	16,597,000	1,961,000	6,129,000	15,580,000	-1,444,000	-624,000	6,242,000	4,531,000	-4,413,000	7,926,000	4,427,000	2,549,000	3,355,000	2,677,000
proceeds from issuance of common stock under employee stock purchase plan		0																											620,000	0
taxes paid related to stock-based awards		-248,000	-720,000	-1,119,000		-68,000	-88,000	-1,436,000		-279,000	-187,000	-1,507,000		-166,000	-158,000	-535,000		-591,000	-677,000	-7,252,000		-476,000	-521,000	-13,831,000		0	-1,040,000	-9,080,000	-546,000	-2,958,000	-127,000	-2,553,000	-174,000	-156,000	-209,000	-2,228,000	-148,000	-153,000
income taxes		-1,000	-169,000	22,000	-1,937,000	-1,376,000	-698,000	29,000	-1,264,000	-432,000	-633,000	-38,000	-292,000	622,000	-2,163,000	51,000	-14,000	-41,000	3,706,000	5,000	10,000	177,000			-20,000	16,000			25,000	20,000	782,000	23,000	567,000	408,000	714,000	64,000	364,000	326,000	500,000	267,000	185,000	355,000	154,000	17,000	200,000	167,000	381,000	33,000	0	630,000	202,000	563,000	421,000	384,000	202,000	111,000	180,000	171,000	145,000	265,000
amortization of investments									-1,113,000	-730,000	-946,000	-907,000	-284,000	182,000	201,000	374,000	365,000	438,000	477,000	649,000	831,000	738,000
net decrease in cash and cash equivalents and restricted cash												-26,254,000											-115,035,000	-315,540,000
shares issued in settlement of laxdale milestone payment
purchase of furniture, fixtures and equipment										-1,000
proceeds from the sale of common stock						0
net income															-69,956,000	-31,563,000	14,698,000	-13,151,000																-10,825,000	-13,634,000	-20,941,000				-29,771,000			-31,512,000	-31,126,000												-88,285,000				18,294,000
adjustments to reconcile net income to net cash from operating activities:
(purchases) disposal of furniture, fixtures and equipment
cash received during the year for:
laxdale milestone																	0	0	0	12,000,000
proceeds from the sale of common stock, net of transaction costs										0
proceeds from exercise of stock options, net of transaction costs										2,000	7,000	1,871,000	1,000	10,000	19,000	30,000	306,000	481,000	75,000	2,059,000	3,297,000	203,000	352,000	1,306,000	4,934,000	2,200,000	1,888,000	15,456,000	9,908,000	14,668,000	278,000	1,548,000	187,000	55,000	100,000	296,000	151,000	12,000	102,000	22,000	0	0	27,000	4,000	0	23,000	-1,000	285,000	0	86,000	102,000	439,000	371,000	1,156,000	5,887,000	791,000	21,000	119,000	3,230,000	1,724,000
amortization of debt discount and debt issuance costs																					34,000	111,000	201,000	289,000	362,000	404,000	432,000	446,000	496,000	547,000	567,000	573,000	596,000	589,000	584,000	563,000	537,000	2,208,000	2,565,000	2,473,000	2,604,000	1,966,000	1,877,000	1,811,000	1,824,000	1,772,000	1,094,000	1,173,000	4,399,000	4,492,000	4,536,000	4,204,000	3,491,000	3,345,000
accrued interest payable																					-80,000	-108,000	-129,000	-111,000	-65,000	-64,000	-8,000	-73,000	61,000	-313,000	269,000	-327,000	468,000	-3,131,000	-1,561,000	-2,267,000	-1,475,000	-3,314,000	599,000	-2,015,000	747,000	-1,410,000	1,303,000	-1,292,000			2,101,000	-405,000	2,073,000	1,346,000	4,911,000	2,124,000	1,426,000	-1,414,000	1,312,000	1,196,000
sale and maturities of securities																	82,144,000	59,066,000	125,159,000	127,925,000	115,275,000	55,274,000
investment in website development costs
disposal (purchases) of furniture, fixtures and equipment
payment of transaction costs for conversion of preferred stock																					-238,000	-28,000							0
payment on debt from royalty-bearing instrument																					-9,420,000	-12,991,000	-14,595,000	-13,330,000
interest																					161,000	689,000	318,000	875,000	1,014,000	-11,405,000	7,273,000	7,709,000	5,497,000	5,779,000	4,378,000	5,873,000	4,705,000	4,990,000	3,435,000	4,111,000	3,244,000	6,171,000	2,530,000	5,138,000	2,334,000	4,396,000	1,556,000	4,273,000	1,411,000	3,890,000	1,096,000	3,636,000	840,000	2,625,000	0	2,625,000	0
conversion of series a convertible preferred stock into common stock																																									0	0
disposal of furniture, fixtures and equipment																				4,000
proceeds from the issuance of common stock, net of transaction costs
adjustments to reconcile income to net cash from operating activities:
cash (paid) received during the year for:
proceeds from issuance of common stock, net of transaction costs																		0				0			-837,000	440,108,000			194,833,000	0	0	70,007,000					-1,000												0								0	0	-17,000	98,671,000
cash received (paid) during the year for:
disposal (purchase) of furniture, fixtures and equipment																		0
transaction costs related to exchange of exchangeable senior notes																																					-2,000
exchange of exchangeable senior notes into common stock																																					0
proceeds from sales of securities																								17,077,000
purchase of securities																								-310,648,000
deferred income taxes																																					11,932,000	-1,288,000	-1,400,000	-446,000	-2,670,000	-851,000	-636,000	-95,000	-3,696,000	75,000	31,000	-24,000	2,955,000	-1,553,000	-887,000	-3,949,000
proceeds from issuance of exchangeable debt																																	0	0
payment of debt issuance costs																																	0	0	0	-1,207,000
repurchase of exchangeable senior notes, including transaction costs
payment on long-term debt from royalty-bearing instrument																									-10,211,000	-8,908,000	-6,110,000	-6,423,000	-4,151,000	-3,826,000	-2,928,000	-3,785,000
other receivables
purchases of equipment																													-5,000				0	0	0	-12,000					-18,000								0	0	0	-14,000	-72,000	-213,000	-172,000	-92,000	-365,000
loss on sale of fixed assets																																						0	0	48,000
allowance for doubtful accounts
gain on change in fair value of derivative liabilities																																								1,250,000
repurchase of exchangeable senior notes																																		0	0	-15,107,000
stock-based compensation—warrants																																									0	0	0	-9,000	0	-326,000	-105,000	-72,000	-2,524,000	276,000	-1,004,000	-451,000	-2,790,000	-1,195,000	1,858,000	2,374,000	-1,100,000	-3,352,000	5,035,000	-679,000
gain on extinguishment of debt																																													0	0
proceeds from issuance of preferred stock, net of transaction costs																																									0	5,517,000	-104,000	52,253,000
proceeds from issuance of convertible debt, net of transaction costs
proceeds from exercise of warrants, net of transaction costs																																									0	0	0	2,713,000	0				40,000	50,000	0	70,000	194,000	1,596,000	14,871,000	59,000	41,000	3,731,000	8,476,000	6,454,000
debt issuance costs																																													0	-55,000
payment under capital leases
net decrease in cash and cash equivalents																																			-10,612,000	-2,175,000					-12,015,000					-15,093,000	-13,750,000	-27,236,000
cash and cash equivalents, beginning of period																																	0	0	0	98,251,000	0	0	0	106,961,000	0	0	0	119,539,000	0	0	0	191,514,000	0	0	0	260,242,000	0	0	0	116,602,000	0	0	0	31,442,000
cash and cash equivalents, end of period																																	-5,449,000	-6,378,000	-10,612,000	96,076,000	-19,311,000	45,071,000	-8,872,000	81,363,000	-12,015,000	-17,074,000	-25,145,000	161,195,000	-15,896,000	-15,093,000	-13,750,000	164,278,000	-34,371,000	76,459,000	-52,354,000	201,780,000	45,132,000	-35,145,000	4,433,000	245,822,000	-9,253,000	-5,591,000	1,964,000	129,482,000
transfer of preferred stock purchase option derivative liability to equity																																									0	0	0	868,000
accretion of preferred stock beneficial conversion features																																									0
reacquisition of conversion option in convertible notes																																													0
net increase in cash and cash equivalents																																						45,071,000	-8,872,000	-25,598,000			-25,145,000	41,656,000					-34,371,000	76,459,000	-52,354,000	-58,462,000	45,132,000	-35,145,000	4,433,000	129,220,000	-9,253,000	-5,591,000	1,964,000	98,040,000
loss on change in fair value of derivative liabilities																																						-3,610,000												1,402,000
proceeds from issuance of convertible debt																																				30,000,000
loss on sale of property, plant and equipment
(gain) loss on change in fair value of derivative liabilities
refund of equity issuance costs																																													0
payments under capital leases																																									0	0	-3,000	-2,000	28,000	-25,000	-13,000	-26,000						0	-19,000	-1,000
supplemental disclosure of non-cash items:
depreciation																																						35,000
inventories																																						533,000	1,038,000	-2,359,000	719,000	795,000	-4,316,000	-2,450,000	-1,847,000	5,257,000	4,687,000	4,861,000				-6,173,000
other non-current assets																																									-98,000	211,000	189,000	129,000	1,997,000	295,000	383,000	1,339,000	975,000	0	-1,000	-383,000	16,295,000	-11,822,000	-3,483,000	-2,050,000
other non-current liabilities																																						463,000	-32,000	-35,000	-273,000	-18,000	-5,000	245,000												2,793,000
purchase of equipment																																						0	0	-21,000
non-cash transactions:
accretion of preferred stock beneficial conversion feature
excess tax provision on stock-based awards																																								94,000			89,000	552,000
acquisition of treasury stock																																								-694,000	-43,000	-34,000	0	-117,000
gain on changes in fair value of derivative liabilities																																											600,000	-464,000		-4,466,000	-3,011,000	-4,393,000
change in lease liability																																																	3,000	22,000	-12,000	-7,000	5,000	-9,000	-38,000	-8,000	18,000	11,000	-38,000	-12,000
shares issued for services																																																	0	9,000	10,000	8,000	8,000	10,000	8,000	6,000				6,000
restricted cash																																													0	0	0	400,000	400,000	0	0	-1,400,000
repurchase of convertible notes, including transaction costs
excess tax benefit from (provision on) stock-based awards
reclassification of warrant liability to additional paid-in capital
excess tax provision on (benefit from) stock-based awards
loss on changes in fair value of derivative liabilities																																																				-3,620,000
excess tax (provision on) benefit from stock-based awards																																										-66,000
excess provision on stock-based awards																																												-552,000
excess tax benefit from stock-based awards																																													2,300,000	0	0	-1,000	605,000	37,000	-325,000	-678,000	-1,228,000	-2,146,000	-6,076,000	-1,884,000	-2,628,000	-510,000
foreign exchange loss on intangible asset
(gain) loss on changes in fair value of derivative liabilities
other current and prepaid assets
purchase of long-term investment
purchase of intangible asset
proceeds on issuance of exchangeable senior notes, net of transaction costs
proceeds from long-term debt, net of transaction costs
reclass of warrant liability to additional paid-in capital
current portion of long-term debt
other current assets																																														-59,000	68,000	-1,380,000	1,973,000	-1,365,000	4,880,000	-3,798,000	857,000	2,323,000	-1,465,000	-3,131,000				586,000
supplemental disclosure of non-cash items: reacquisition of conversion option in convertible notes
excess tax provision from stock-based awards																																																1,000
accounts payable and other liabilities																																																-3,105,000			-11,680,000	14,993,000		18,570,000	13,368,000	1,137,000				-3,217,000
proceeds from long term debt, net of transaction costs
repayment of capital leases
accounts payable, accrued expenses and other liabilities
proceeds from issuance of exchangeable debt, net of transaction costs																																																						0	0	144,316,000
transfer from derivative liability to equity, fair value of warrants exercised																																																						11,603,000	91,961,000	321,000		21,000,000	79,229,000	29,229,000
proceeds from issuance of senior notes, net of transaction costs
reclass of derivative warrant liability to additional paid-in capital
purchase of long term investment																																																					-412,000	-413,000			0
laxdale intangible asset
expense for commitment fee
amortization of laxdale milestone
loss on change in fair value of derivative liability																																																						-16,453,000	18,930,000	66,209,000
gain on sale of intellectual property
stock-based compensation—ester
non-cash interest
loss on changes in fair value of derivative liability																																																									-30,734,000	-106,614,000	185,359,000	-25,342,000
sale of lorazepam
proceeds on issuance of convertible debt
repayment of convertible debt
repayment of finance leases
reclass of additional paid-in capital to warrant liability
conversion of bridge loans
issuance of ester shares
issuance of proseed shares
stock issued for services																																																										13,000
other assets																																																										-1,083,000
accounts payable, accrued expenses, and other liabilities																																																										3,235,000
cash flows from operating activities
loss after tax
adjustments:
depreciation of property, plant and equipment
amortization of intangible assets
impairment of intangible assets
(increase)/decrease fair value of available for sale investment
share based payments
share based payments — warrants
effect of exchange rate changes on assets/liabilities and other items
interest received
interest expense
interest on finance leases
increase in other liabilities
decrease/(increase) in other current assets
decrease in current liabilities
(decrease)/increase in provisions
fair value (gain)/loss on derivative financial liability through income statement
r&d tax credit
cash expended on operating activities
tax refund
net cash outflow from operating activities
cash flows from investing activities
purchase intangible assets
sale of lorazapam
purchases of property, plant and equipment
net cash inflow/(outflow) from investing activities
cash flows from financing activities
proceeds from issue of share capital
net proceeds on the issue of convertible debentures
interest paid
expenses on issue of share capital
expenses on issue of convertible debentures
repayment of finance lease
net cash inflow from financing activities
net increase/(decrease) in cash and cash equivalents
cash and cash equivalents at the beginning of the year
exchange rate gains on cash and cash equivalents
cash and cash equivalents at end of year
amortization of convertible bridge loan
share based compensation
interest paid on finance leases
decrease in other current assets
decrease in provisions
fair value loss /(gain) on derivative financial liability through income statement
purchase of property, plant and equipment
net cash (outflow)/inflow from investing activities
borrowings received
net (decrease)/increase in cash and cash equivalents
cash and cash equivalents at beginning of period
effect of exchange rate changes on cash and cash equivalents
cash and cash equivalents at end of period
finance income on option
(decrease)/increase in other liabilities
fair value gain on derivative financial liability through income statement
net cash inflow from investing activities
impairment of property, plant and equipment
effect of exchange rate changes on assets/liabilities and other items*
(increase)/decrease in other current assets
increase/(decrease) in other liabilities
effect of exchange rates on foreign currency cash balances
cash and cash equivalents at the end of the year
options granted at the market price risk free interest rate
expected life
volatility
expected forfeiture rate
forced exercise rate
minimum gain for voluntary exercise rate
voluntary early exercise at a minimum gain rate
expected dividend
net (loss) as reported
basic and diluted (loss) per ordinary share
net cash (used) by operating activities
net cash provided/(used) by financing activities
net cash (used)/provided by investing activities
net effect of foreign exchange on cash and cash equivalents
deduct: stock-based employee compensation expense determined under fair value based method for all awards, net of related tax effect
add back total stock based compensation expense determined under the intrinsic value based method
pro forma net
net cash used by operating activities
net cash (used)/provided by financing activities
net cash provided/(used) by investing activities
cash at beginning of period
cash outflow on investing activities
cash inflow from financing activities
movement in cash and cash equivalents
cash and cash equivalents at beginning of year
cash and cash equivalents at the end of year
net cash (outflow)/inflow from operating activities
cash and cash equivalents at the beginning of the period
cash and cash equivalents at the end of the period
proforma net
net cash used by investing activities
net provided by operating activities
basic and diluted (loss) per ordinary share as reported
proforma
weighted-average grant date fair value options granted at the market price
options granted at a premium to the market price
options granted at a discount to the market price
operating profit including discontinued activities
adjustments to reconcile operating loss to net cash from operating activities:
depreciation of tangible fixed assets
amortisation of intangible fixed assets
changes in assets and liabilities
prepaid expenses and accrued income
accounts payable
other current liabilities
exchange differences
total adjustments
returns on investments and payment for interest
interest on finance leases and purchase contracts
net cash from returns on investments and payment for interest
taxation
taxation received
purchase of intangible fixed assets from related party
purchase of intangible fixed assets
cash eliminated on sale of south american transdermal business
sale of property, plant and equipment
proceeds on sale of uk transdermal business to related party
cash flows from management of liquid resources
proceeds on sale of current asset investments
increase in short term deposits with banks
net cash from management of liquid resources
issuance of ordinary shares
expenses on issuance of ordinary shares
restructuring costs paid
(repayment)/proceeds of bank loans
payments under lease and purchase contracts
new bank and other loans
borrowings under short term loan arrangements
net increase in cash
cash at beginning of year
cash at end of year

Amarin Corporation plc(NASDAQ:AMRN)

Amarin Corporation plc
(NASDAQ:AMRN)